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Colorectal cancer (CRC) is the second leading cause of cancer-related deaths in 
the Western world. Despite curative surgery, approximately 40% of patients still 
experience disease relapse leading to morbidity and eventual mortality. For the last few 
decades, 5-fluorouracil (5-FU) is the treatment of choice in both the adjuvant and 
advanced treatment of CRC. However, a high proportion of these patients will develop 
recurrent disease within their lifetime. Therefore there is an urgent demand to develop 
markers that can identify which of these patients would benefit from 5-FU therapy. 
The aim of this study is to investigate the effect of 5-FU in the mRNA and 
proteins expression in a human colon cancer cell line SW480 which shows nuclear 
accumulation of p-catenin. Quantitative reverse transcriptase polymerase-chain reaction 
(Q-RT-PCR) arrays were used to measure the expression of 84 genes involved in Wnt-
mediated signal transduction. Results indicated that after treating the SW480 cells with 
5-FU for 72 hours, frizzled-related protein (FRZB)，dickkopf homolog 1 (DKKl), Wnt-
9A, FOS-like antigen 1 (FOSLl), porcupine (PORCN) homolog, Myc，dishevelled dsh 
homolog 1 (DVLl), frequently rearranged in advanced T-cell lymphomas (FRAT), Jun 
oncogene, APC, paired-like homeodomain transcription factor 2 (PITX2), cyclin D3 and 
B-cell CLL/ lymphoma 9 (Bcl-9) were upregulated whereas sex determining region Y-
box 17 (S0X17)，Wnt-11 and Wnt-2 were downregulated with at least 2-fold differential 
expression when compared to that without 5-FU treatment. 
As the advent of high-throughput technologies enable cancer samples to be 
profiled on a global scale, proteomic profiling with proteins identification were also used 
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to examine the effect of 5-FU in SW480 cells. Two-dimensional electrophoresis (2-DE) 
indicated that 114 spots were upregulated and 90 spots were downregulated with at least 
2-fold differential expression. Moreover, 14 spots with the highest fold change were 
excised for protein identification. Upregulated proteins were identified as cyclophilin A, 
cytokeratin 8 (CK8)，cytokeratin 19 (CK19)，Ras-related nuclear protein (RAN), heat 
shock protein 27 (hsp27), peroxiredoxin 6 (Prx 6) and downregulated proteins were 
identified as nucleoside nm 23, a-enolase (ENOl), carbamoylphosphate synthetase I 
(CPSl), cytokeratin 9 (CK9)，cytokeratin 18 (CK18), p-actin, heat shock protein 70 
(hsp70) and heat shock protein 60 (hsp60). Those proteins belong to several families 
which involve in cell signaling, epithelial cells development, enzymatic reactions, 
proteins folding and transport. Verification of the proteomic findings by antibody 
stainings was performed on 5-FU treated and untreated SW480 cells, three (hsp27, Prx 6 
and hsp70) of the identified proteins were found to have the same expression pattern as 
those from 2-DE. 
The information got from this study would lay down a solid foundation in the 
development of markers that can predict the tumor response to 5-FU treatment, and in 
the long run, may enable the clinicians to tailor treatment according to an individual 
patient tumor response profile. 
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Colorectal cancer (CRC) is one of the leading cancer-related deaths in the world. 
Despite curative surgery, approximately 40% of patients still experience disease relapse 
leading to morbidity and eventual mortality (Cabibi et al., 2004). Despite the relative 
low clinical response rate of around 10%, 5-fluorouracil (5-FU) served as the primary 
treatment for patients with metastatic CRC in the past decades. During the last 15 years, 
a large number of controlled clinical trials have attempted to reduce relapse rate by using 
5-FU in patients with stage II-III CRC. The results have clearly demonstrated that 
adjuvant chemotherapy can bring about a statistically significant 33% reduction in 
mortality in the high-risk populations of patients with stage III disease (Correale et al, 
2006). Efforts to improve responses rate have led to the combination therapy of 5-FU 
with newer cytotoxic drugs, oxaliplatin and irinotecan, which have significantly improve 
the response rate to around 50% and prolonged progression-free survival in metastatic 
CRC (Goldberg 2006). Even though improvement have been made by the combination 
therapy，patients who respond to 5-FU ultimately become resistant (Chau et al., 2002) 
and a high proportion of these patients will develop recurrent disease within their 
lifetime (Goldberg 2006). Recent evidence has indicated that thymidylate synthase (TS) 
, amplification is responsible for a significant fraction of 5-FU resistance (Saga et al, 
2003). 
Introduction 
The cytotoxic effect of 5-FU is exerted either by the inhibition of TS activity or 
incorporation into RNA or DNA (Diasio et al, 1989). Cells metabolize 5-FU into 5-
fluorouridine-5‘-triphosphate (FUTP) and 5-fluoro-2'-deoxyuridine-5'-monophosphate 
(FdUMP). The active metabolite FUTP can incorporate into RNA molecules, causing 
the dysfunction of RNA (Tanaka et al” 2000). Another active metabolite FdUMP can 
form a tight tertiary complex with TS, therefore blocking its active site and inhibiting its 
activity in 2‘ -deoxythyniidine-5 ‘ -monophosphate (dTMP) synthesis which is essential in 
DNA synthesis (Parker et al” 1990). 
A major clinical challenge is to identify a subset of patients who could benefit 
from chemotherapy, both in metastatic and adjuvant settings. There have been many 
attempts to determine predictive factors for response. Alterations in gene expression， 
protein expression, and polymorphic variants in genes encoding TS, dihydropyrimidine 
dehydrogenase (DPD), and thymidine phosphorylase (TP) have been reported to predict 
response to 5-FU (lacopetta et al” 2001; Kornmann et al, 2003). In addition, 
microsatellite-instability status is also found to be an independent predictor of 5-FU-
based adjuvant chemotherapy (Ribic et al, 2003), and high mRNA expression of 
excision repair cross-complementing 1 and TS have shown to be predictive of poor 
response to treatment of advanced disease with 5-FU (Shirota et al., 2001). However, 
they have not yet been applied routinely in clinical practice because the majority of 
studies reported to date have looked at small series of arbitrarily selected cases (Adlard 
et al., 2002). Furthermore, an in vitro study on the prediction of response of colon cancer 
cells demonstrated that the measurement of multiple rather than single marker genes 
resulted in a more accurate assessment of drug response (Mariadason et al, 2003). 
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Therefore there is an urgent demand to develop novel markers that can identify which of 
these patients would benefit from 5-FU therapy. 
Wnt signaling plays an important role in normal embryonal development of 
different tissues and regulates growth, apoptosis and differentiation (Behrens et al” 
2005). Wnt factors are secreted proteins that bind to frizzled transmembrane receptors 
and may act in a paracrine or autocrine fashion (Kinzler et aL, 1996). After binding of 
Wnts to Frizzled proteins, the cytoplasmic phosphoprotein, Dishevelled, becomes 
recruited to the plasma membrane (Cong et aL, 2004). This leads to activation of 
Dishevelled which can then interfere with the degradation of cytoplasmic protein p-
catenin (Cong et aL, 2004). As a result, an intracellular signaling cascade is initiated that 
leads to the stabilization of p-catenin, which enters the nucleus and forms complexes 
with high motility group box transcription factors of the lymphoid enhancing factor 
(Lef)/T-cell factor (Tcf) family (Behrens et aL, 1996). These Lef/Tcf-(3-catenin 
complexes would activate target genes such as c-myc and cyclin D1 and tumor 
formation may result (Figure 1.1) (Behrens et aL, 1996). In summary, activated Wnt 
signaling pathway plays a critical role in the pathogenesis of CRC. As the expression of 
cytoplasmic p-catenin are normally controlled by a multiprotein destruction complex 
including the tumor suppressor adenomatous polyposis coli (APC), the glycogen 
synthase kinase 3p (GSK-3p) and casein kinase la/s that targets (3-catenin for 
degradation in proteasomes by phosphorylation (Polakis P，2000), high prevalence of 
gene mutations activating the Wnt pathway in CRC makes it an attractive target for 
pharmacological interventions aimed at inhibiting the activity of P-catenin. In fact, the 
validity of this approach has been confirmed in several recent studies where interference 
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with Tcf/p-catenin signaling has led to inhibition of CRC cell proliferation. These 
examples include the expression of either E-cadherin (Stockinger et al, 2001) or a 
dominant-negative Tcf mutant (van de Wetering et al, 2003) is sufficient to arrest cell 
growth by interfering with p-catenin signaling. Besides，knock-down of p-catenin by 
targeted inactivation (Chan et al, 2002) or anti-sense treatment (Roll et al, 2001) can 
inhibit the growth of CRC in mice. Therefore interference with aberrant Wnt signaling 
could be of therapeutical value in CRC. 
Introduction 
1 伪 們 
Wnt on，P-cat on 
Figure 1.1 Mechanism of Wnt signaling pathway 
Upon exposure of cells to soluble Wnt ligaiids, which interact with frizzled receptors, it 
recruits a small phosphoprotein deshevelled that inactivates GSK-3P and APC. P-catenin 
is stabilized by several mechanism including mutation of APC, inactivation of GSK-3(3 
and casein kinase. Stabilized p-catenin translocates to the nucleus, where it binds to 
Tcf/Lef transcription factors and regulating the transcription of target genes. 
— 
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The well-characterized human CRC cell line SW480 was chosen as a model in 
this study, because it has been found to contain a constitutively high level of nuclear (3-
catenin expression, which is a key trigger in the dysregulation of the Wnt signaling 
pathway that plays an important role in the evolution of CRC (He et aL, 1998). 
In this study, quantitative PGR array was used to measure the expression of 84 
genes related to Wnt-mediated signal transduction in SW480 cells with 5-FU treatment. 
The quantitative PCR array combines the advantage of quantitative reverse transcriptase 
polymerase-chain reaction (Q-RT-PCR) and niicroarray which allows detection of the 
expression of 84 genes simultaneously. The genes investigated belong to several 
families related to Wnt-mediated signal transduction. These include extracellular 
signaling molecules, members of canonical Wnt signaling pathway, regulators of cell 
cycle, regulators of growth and proliferation, regulators of transcription, regulators of 
Wnt receptor signaling pathway and other genes involved in Wnt signaling. 
Recent improvements in two-dimensional electrophoresis (2-DE), image analysis, 
mass spectrometry, the development of advanced bioinformatics databases and analysis 
software, have enabled the proteomics technology to identify disease-associated protein 
markers that are helpful in diagnosis or prognosis (Wulfkuhle et aL, 2003). Currently, 
there is a growing body of evidence revealing the great potential of proteomics 
technology in the analysis of response and resistance of tumor cells to cytotoxic drugs 
(Urbani et aL, 2005). With the advanced of proteomics technologies, matrix-assisted 
laser desorption ionization (MALDI) time-of-flight (TOF) mass spectrometry (MS) was 
used to study the 5-FU treatment response proteins in SW480 cells. • 
Introduction 
The aim of this study is to investigate the effect of 5-FU in both the mRNA and 
proteins expressions in SW480 cells using Q-RT-PCR and proteomics profiling 
respectively. The information obtained would be important for a more detailed 
understanding in the CRC response to 5-FU, and possibly help to discover novel 





2.1 Literature review 
2.1.1 Colorectal cancer 
CRC is one of the most common cause of cancer-related deaths in the Western 
world. Despite curative surgery, approximately 40% of patients still experience disease 
relapse leading to morbidity and eventual mortality (Cabibi et al., 2004). For the last few 
decades, 5-FU is the most common chemotherapeutic agent in treating both the adjuvant 
and advanced CRC. However, patients who respond to 5-FU ultimately become resistant 
(Chau et al., 2002) and a high proportion of these patients will develop recurrent disease 
within their lifetime (Mariadason et al, 2003). Therefore there is an urgent demand to 
develop markers that can identify which of these patients would benefit from 5-FU 
therapy. 
2.1.2 Incident rate of colorectal cancer 
Regarding to the statistics released by American Cancer Society, CRC is the 
third leading cancer for the estimated new cases in the United States for both sexes in 
2005，with an incident rate of around 10% and 11% in all cancer types in male and 
female, respectively (Jemal et al” 2005). 
Colorectal cancer 
The situation in Hong Kong is similar to the rest of the world. According to the 
statistics for 2004 published by the Hong Kong Cancer Registry, CRC is the second 
most common cancer in Hong Kong for both sexes and the relative frequencies for male 
and female are 16.4% and 15.4%, respectively. 
2.1.3 Hereditary colorectal cancer 
There are two main forms of inherited CRC, including hereditary nonpolyposis 
colorectal cancer (HNPCC) and familial adenomatous polyposis (FAP). HNPCC, or 
Lynch syndrome, inherited in an autosomal dominant fashion, is the most common form 
of hereditary CRC, accounting for approximately 1% to 6% of all colorectal 
malignancies (Aaltonen et al” 1998). Mutations in five mismatch repair genes, including 
hMSH2 on chromosome 2p，hMLHl on chromosome 3p and the less common mismatch 
repair genes hPMSl，hPMS2 and hMSH3 are implicated in the pathogenesis of this 
disease (Strate et al., 2005). 
FAP is autosomal dominantly inherited and account for less than 1% of all CRC. 
The disorder is marked by the emergence of numerous colorectal adenomatous polyps 
and is mainly due to the mutations in APC gene. The APC gene is a tumor suppressor on 
chromosome 5q21 and over 90% of these mutations are nonsense mutations or 
frameshift mutations leading to premature stop codons, thus the encoded proteins are 
truncated and nonfunctional (Strate et al, 2005). 
— 
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2.1.4 Sporadic colorectal cancer and Wnt signaling pathway 
Sporadic cancer syndromes attribute to a large proportion of CRC, and a series of 
mutations is needed for sporadic CRC to develop. Mutations in APC are seen in around 
70% of sporadic tumors, which often occur early in the development of CRC. Other 
tumor suppressor genes involved in CRC include p53 which is mutated in 75% of 
sporadic tumors, and K-RAS oncogene which is mutated in 50% of all sporadic CRC 
cases (Aguilera et aL, 2006). 
In the vast majority of sporadic CRC cases in human, the rate-limiting and 
initiating event is represented by the constitutive activation of the Wnt signaling 
pathway (Moon et al., 2002). Wnt proteins are a family of highly conserved secreted 
proteins that regulate multiple developmental processes, including proliferation of 
organ-specific stem/progenitor cell populations, growth control and cell fate 
determination in diverse organs, and tissue patterning. The Wnt signaling pathway is 
initiated by binding of Wnt factors to receptors and coreceptors, Frizzled and LRP, 
respectively, on the cell membrane (Kinzler et al., 1996)，which triggers a signaling 
cascade that leads to the accumulation of P-catenin (Cong et al., 2004). In the absence of 
Wnts, p-catenin is degraded by a multiprotein complex composed of APC, GSK-3p, 
CKl and the scaffold proteins Axin 1 and Axin 2, which induces the phosphorylation of 
p-catenin and its subsequent proteosomal degradation (Behrens et al., 1996). In the 
presence of Wnt, accumulated p-catenin in the nucleus would associate with Tcf/Lef 
transcription factors to activate target genes that enhance proliferation and cell survival. 
Aberrant activation of Wnt/p-catenin signaling, due to mutations in components of the 
pathway, is thought to be an initiating event in colon carcinogenesis (Behrens et al., 
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1996). Mutations in APC are the earliest and most frequent events in colon tumors, 
whereas mutations in other components of the pathway, including P-catenin itself, have 
been reported but are less frequent (Polakis P, 2000). 
In summary, activated Wnt signaling pathway plays a critical role in the 
pathogenesis of CRC. High prevalence of gene mutations activating the Wnt pathway in 
CRC makes it an attractive target for pharmacological interventions aimed at inhibiting 
the activity of p-catenin. In fact, over the past 2 decades, the understanding of Wnt 
signaling has been significantly improved due to the identification of many key 
regulators and mediators of these pathways (Stockinger et al, 2001, van de Wetering et 
al, 2003). Given that Wnt signaling is tightly regulated at extracellular, cytoplasmic and 
nuclear levels which offer ample nodal points for targeted therapeutics. Therefore a 
more intensive understanding of 5-FU effect in the Wnt signaling molecules in CRC 
cells is essential for us not only to develop markers that may indicate 5-FU benefit in 
CRC patients, but also may have therapeutic value in the long run. 
2.1.5 Chemotherapy treatment of colorectal cancer 
Despite having a relatively low clinical response rate of around 10%, 5-FU 
served as the primary systemic treatment for patients with metastatic CRC in the past 
decades. Efforts to improve responses rate have led to the combination therapy of 5-FU 
with newer cytotoxic drugs oxaliplatin and irinotecan, which have significantly improve 
the response rate to around 50% and prolonged progression-free survival (Goldberg 
2006). 
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2.1.5.1 5-FluorouraciI 
5-FU is usually administered in combination with leucovorin, which is a 
biomodulating agent that enhances the effects of 5-FU by stabilizing the binding of 5-FU 
to TS. This approach increases CRC response rates from 11% with 5-FU alone to 23% 
with combination therapy with leucovorin (Mayer, 2000). 
The cytotoxic effect of 5-FU is exerted either by the inhibition of DNA synthesis 
or incorporation into RNA (Diasio et aL, 1989). Cells metabolized 5-FU into FUTP and 
FdUMP through a series of phosphorylation (Figure 2.1). The active metabolite FUTP 
can incorporate into RNA molecules, causing the dysfunction of RNA (Tanaka et aL, 
2000). Another active metabolite FdUMP can form a tight tertiary complex with TS, 
therefore blocking its active site and inhibiting its activity in dTMP synthesis (Parker et 
aL, 1990). 
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Inhibition of DNA synthesis 
Figure 2.1 The mechanism of 5-fluorouracil action 
FUMP: fluorouracil monophosphate 
FUDP: fluorouridine-diphosphate 





Oxaliplatin has distinct biochemical, pharmacological and cytotoxic properties 
compared with the related platinum compounds cisplatiii and carboplatin (Rixe et al, 
1996). Oxaliplatin is cell cycle-nonspecific and undergo non-enzymatic conversion to its 
active derivatives. Oxaliplatin exerts its killing effect mainly by the formation of 
platinum-DNA intrastrand adducts and DNA-protein interstrand crosslinks, therefore 
blocking DNA replication and transcription (Raymond et al, 1998, Woynarowski et al, 
2000). Unlike cisplatin and carboplatin, oxaliplatin carries the diaminocyclohexane 
(DACH) ligand, which allows DNA lesions to avoid DNA mismatch repair and DNA 
damage recognition pathways (Vaisman et al’ 1998). The use of oxaliplatin results in the 
formation of DACH-platinum-DNA adducts which eventually leads to DNA-strand 
breaks and the induction of apoptosis (Arango et al’ 2004). 
2.1.5.3 Irinotecan 
Irinotecan is a semi-synthetic derivative of camptothecin, an alkaloid extract 
from camptotheca acuminate (Wasserman et al” 2001). Irinotecan belongs to the class 
of topoisomerase I inhibitors. Topoisomerase I is a DNA enzyme responsible for 
controlling and modifying DNA during replication and translation of genetic materials. 
Irinotecan and its active metabolite, SN-38, bind to the topoisomerase DNA complex 
and prevent religation of the single-strand breaks in the DNA molecule, therefore DNA 
transcription and replication are restrained (Guo et al” 2004). 
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2.1.6 Biomarkers for colorectal cancer 
Resistance to 5-FU chemotherapy limits the effectiveness of current CRC 
therapies. Drugs resistance can be intrinsic or acquired during treatment and is believed 
to cause treatment failure in over 90% metastatic cancer patients. On the other hand, 
many factors contribute to the regulation of drug sensitivity, such as the pharmacokinetic 
profile of the drug, alternation in drug targets and drug activation (Longley et al., 2006). 
Discovering molecular and biochemical markers that can be used as predictors of 
response to treatment so that CRC patients with no response to 5-FU can be recognized 
and other treatment strategies can be applied to those patients. 
Based on previous literatures findings, TS, DPD，TP，and microsatellite-
instability status are the most extensively studied 5-FU biomarkers. 
2.1.6.1 Thymidylate synthase 
In metastatic CRC, TS protein and mRNA expression have been found to 
correlate with response to 5-FU chemotherapy, with high TS expression correlating with 
increased 5-FU resistance (Longley et al, 2003). The 5-FU metabolite FdUMP forms a 
stable complex with TS to block its active site and hence inhibiting thymidylate 
synthesis (Longley et al” 2003). A number of studies have also investigated the 
relationship between TS expression and survival in CRC patients. It was found that 
tumor expressing high levels of TS had a poorer overall survival compared with tumors 
expressing low level (Popat et al, 2004). 
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2.1.6.2 Dihydropyrimidine dehydrogenase 
Tumoral DPD has been reported to be an important determinant of response to 5-
FU chemotherapy, in which high expression level of DPD correlates with increased 5-
FU resistance (Takebe et al, 2001). DPD is responsible in catalyzing the rate-limiting 
step in the catabolism of fluoropyrimidines, thereby limiting the bioavailability of 5-FU 
(Diasio et al, 1989). 
2.1.6.3 Thymidine phosphorylase 
It has been shown that tumors with high TP expression are more resistant to 5-
FU (Takebayashi et al, 1996). TP converts 5-FU into fluorodeoxyuridine, which can 
then be converted into the active metabolite FdUMP (Takebayashi et al., 1996). In the 
presence of FdUMP, TS activity in dTMP synthesis will be inhibited, and hence leading 
to inhibition in DNA synthesis (Parker et al” 1990). 
2.1.6.4 Microsatellite-instability status 
CRC with high-frequency microsatellite instability have clinical and pathological 
features that distinguish them from microsatellite-stable tumors. The form of genetic 
destabilization caused by the loss of DNA mismatch-repair function is referred as the 
microsatellite-instability pathway (Gryfe et al, 2000)，whereas genetic alterations 
including allelic losses, loss of heterozygosity, chromosomal amplifications, and 
translocations are referred as microsatellite-stability pathway (Lengauer et al, 1998). It 
has been shown that 5-FU-based adjuvant chemotherapy benefits patients with stage II 
or stage III CRC with microsatellite-stable tumors or tumors exhibiting low-frequency 
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microsatellite instability but not those with tumors exhibiting high-frequency 
microsatellite instability (Ribic et al” 2003). 
2.1.6.5 Clinical uses of biomarkers for colorectal cancer 
The above 5-FU markers have not yet been applied routinely in clinical practice 
because the majority of studies reported to date have looked at small series of arbitrarily 
selected cases (Adlard et al, 2002). Furthermore，an in vitro study on the prediction of 
response of CRC cells demonstrated that the measurement of multiple rather than single 
marker genes resulted in a more accurate assessment of drug response (Mariadason et 
2003). Therefore there is an urgent demand to develop novel markers that can identify 
which of these patients would benefit from 5-FU therapy. 
2.1.7 Choice of cell line as colorectal cancer model 
The well-characterized human CRC cell line SW480 was chosen as a model in 
this study, because it has been found to contain a constitutively high level of nuclear p-
cateniii expression, which is a key trigger in the dysregulation of the Wnt signaling 
pathway that plays an important role in the evolution of CRC (He et al, 1998). Human 
colonic fibroblast cell line CCD-I8C0 was included as a control. 
2.1.8 Aims of study 
Aberrant activation of Wnt signaling and subsequent up-regulation of (3-catenin 
mediated transcription is a critical event in the development of human CRC, therefore 
Wnt signaling pathway is an attractive target for the development of anticancer 
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therapeutics. To our understanding, no study has ever demonstrated the direct effect of 
5-FU oil Wnt signaling pathway. However，Wnt signaling has been implicated in several 
drugs response in human CRC cell lines. Hexachlorophene has been found to antagonize 
P-catenin response transcription by promoting the APC-dependent degradation of p-
catenin (Park et aL, 2006). In addition, hexachlorophene represses the expression of 
cyclin Dl, which is a known p-catenin target gene, and the growth of CRC cells is 
inhibited (Park et al, 2006). In addition, non-steroidal anti-inflammatory drug 
diclofenac has been found to inhibit Wnt signaling through the activation of NF-kappaB 
in CRC cells (Cho et al, 2005). The transcriptional factor NF-kappaB is an important 
signal transduction molecule that participates in the induction of a wide variety of 
cellular genes involved in immunity, inflammation, and regulation of apoptosis (Bours et 
al, 2000). Binding sites for NF-kappaB are present in the promoter region of many 
genes, such as those encoding cell adhesion molecules, cytokines, and growth factors 
(Bours et al, 2000) and activation of NF-kappaB requires GSK-3P (Hoeflich et al, 
2000). As p-catenin can physically complex with NF-kappaB (Deng et al, 2002), there 
is a possibility that p-catenin might serve as a mediator for the cross-regulation between 
Wilt signaling and NF-kappaB pathways. 
Based on these previous studies, chemotherapeutic drugs can affect Wnt 
signaling pathway. Five-FU，a primary systematic treatment for CRC patients who may 
ultimately become resistant to it when prolonged use (Chau et al, 2002). Therefore this 
study is designed to investigate the effect of 5-FU in both the mRNA and proteins 
expressions in order to detect novel predictive markers to 5-FU treatment. 
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Since Wnt signaling pathway is involved in drug response in human CRC cells 
(Park et al, 2006，Cho et al” 2005)，Q-RT-PCR array was used to determine the effect 
of 5-FU on the niRNA expression of Wnt signaling pathway related genes. The 
examination of genes expression alone is not sufficient because expression of mRNA 
may not lead to the expression of its encoding proteins molecules due to mutations in 
genes and errors introduced during transcription and translation (Roeder 2005). Besides, 
proteins are the molecules that actively participate in cellular metabolism, therefore 
proteomics profiling was also performed in this study to investigate the differential 
proteins expression in response to 5-FU treatment. 
In summary, the research plan of the present study was as follows. The CRC cell 
line model, SW480, was first verified as a p-catenin positive cell line by 
immunocytochemical (ICC) staining. The effect of various anticancer drugs, including 
5-FU, oxaliplatin and irinotecan, on SW480 cells viability were then determined by 
MTT assay. To carry on with the study, the effect of 5-FU on the mRNA and proteins 
expression were determined by Q-RT-PCR and proteomics profiling, respectively. 
Finally, the identities of some differentially expressed proteins were verified by ICC 
staining (Figure 2.2). The information obtained would improve our understanding in the 
CRC cells response to 5-FU, and possibly help to discover novel predictive markers to 
5-FU treatment in CRC patients. 
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Verification of SW480 as a p-catenin positive cell line by 
immunocytochemical staining 
少 
Determination of the effect of anticancer drug 5-fluorouracil on SW480 
cells viability by MTT assay 
� f 
Determination of the effect of 5-fluorouracil on the mRNA expression of 
SW480 cells by Quantitative Reverse Transcription-Polynierase Chain 
Reaction (Q-RT-PCR) arrays 
Determination of the effect of 5-fluorouracil on the proteins expression of 
SW480 cells by two-dimensional electrophoresis and peptide mass 
fingerprinting by mass spectrometry 
Verification of proteins' identities by immunocytochemical staining 
Figure 2.2 Outline of the experimental flow of this project 
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2.2 Materials and Methods 
2.2.1 Verification of SW480 as a nuclear p-catenin positive cell line 
2.2.1.1 Maintenance of cell lines 
Human CRC cell line SW480 was obtained from the American Type Culture 
Collection (CCL-228, Manassas, VA). Cultures were maintained in RPMI medium 
(Invitrogen Corporation, Carlsbad, CA，USA) supplemented with 10% heat-inactivated 
(56°C, 30 minutes) fetal calf serum (Invitrogen Corporation, Carlsbad, CA, USA), 100 
U/mL penicillin and 100 ^ig/mL streptomycin (Invitrogen Corporation, Carlsbad, CA, 
USA). Human colonic fibroblast cell line CCD-I8C0 was obtained from the American 
Type Culture Collection (CRL-1459, Manassas, VA). Cultures were maintained in Eagle 
Minimum essential medium (American Type Cell Collection, Manassas, VA) 
supplemented with 10% heat-inactivated (56°C, 30 minutes) fetal calf serum (Invitrogen 
Corporation, Carlsbad, CA, USA), 100 U/mL penicillin and 100 |_ig/mL streptomycin 
(Invitrogen Corporation, Carlsbad, CA, USA). The cell lines were incubated in a 
humidified incubator at 37°C supplemented with 5% carbon dioxide until logarithmic 
growth phase was reached before harvesting. 
2.2.1.2 Antibody 
Anti-p-cateniii monoclonal antibody (CI 9220，Trasduction Laboratories, 
Lexington, Kentucky, USA) was used. 
IIT： 
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2.2.1.3 Agar block preparation for SW480 and CCD-I8C0 cells 
SW480 and CCD-I8C0 cells were harvested by trypsinization and were then 
centrifuged at 1100 rpm for 5 minutes to obtain the cell pellet. The cells harvested after 
trypsinization were fixed in 10% buffered formalin for 18 hours followed by 
centrifuging at 1560 g for 10 minutes. The supernatant was discarded and 500 [iL of 2% 
agar was added to the cell pellet. The mixture was then placed on ice to solidify the agar 
with the cells followed by routine tissue processing to become paraffin embedded blocks 
for immunocytochemical (ICC) staining. 
2.2.1.4 Immunocytochemical staining 
Serial tissue sections (4 \xm thick) were cut and antigen retrieval was performed 
using Bond Epitope Retrieval Solution 2 on the Bond-max automated immunostainer 
(Vision BioSystems, Mount Waverley, Australia) at 100°C for 25 minutes. Primary P-
catenin antibody dilution was prepared as 1:250. Staining was performed according to a 
standard protocol in the immunostainer. Polymer detection system was selected to avoid 
the problem of nonspecific endogenous biotin staining. 
2.2.2 Effect of anti-cancer drugs on cell viability 
2.2.2.1 Maintenance of cell lines 
Human CRC cell line SW480 and human colonic fibroblast cell line CCD-I8C0 
were maintained as previously stated in section 2.2.1.1. Both cell lines were incubated in 
a humidified incubator at 37°C supplemented with 5% carbon dioxide until logarithmic 
growth phase was reached before harvesting. 
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2.2.2.2 MTT cell viability assay 
The effect of anti-cancer drugs on two colorectal cell lines SW480 and CCD-
18Co was examined by MTT assay (Mosmann, 1983). The cells were seeded at a 
desired density in a 96-well flat-bottom tissue culture plate (BD, Franklin Lakes, NJ 
USA) and allowed to attach for 24 hours. SW480 cells were seeded at a density of 
7x1 OV mL of 0.1 mL/well, whereas CCD-I8C0 was seeded at a density of 4x10" niL of 
0.1 mL/well. For comparison purposes, beside 5-FU, other chemotherapeutic drugs 
oxaliplatin, irinotecan were also recruited in the MTT cell viability assay. Increasing 
concentrations of 5-FU (0 {iM, 0.22 pM，2.2 i^M, 22 |jM，220 \iM and 2200 [iM, Ebewe, 
Unterach, Austria), oxaliplatin (0 [iM, 0.0019 i^M, 0.019 i^M, 0.19 pM, 1.9 i^M and 19 
|iM, Laboratories Thissen, Belgium), irinotecan (0 i^M, 0.013 |nM, 0.13 1.3 [lM, 13 
jiM, 130 jiM, Aventis Pharma, Dagenham, United Kingdom) were then added to the 
cells and incubated for up to 72 hours. Cell viability was assessed after 0 hour, 24 hours, 
48 hours and 72 hours using MTT assay (Roche Diagnostics, Basel，Switzerland), which 
10 |liL MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide (5 mg/mL) 
ill phosphate buffer saline (PBS) was added to each well followed by further incubating 
the plates at 37°C for 4 hours. During incubation, the pale yellow MTT would be 
converted to dark blue formazan compound by active mitochondrial dehydrogenase in 
viable cells. Following incubation, 100 [lL solubilization solution (10% SDS in 0.01 M 
HCl) was added to each well to solubilize the dark blue crystal. The plate was further 
incubated at 37°C overnight. The amount of dark blue crystal produced is directly 
proportional to the viable cell present. The absorbance of each well was determined by 
SPECTRA Rainbow microplate reader (MTX Lab Systems Inc, Vienna, Virginia, USA) 
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at a wavelength of 580 nm. Finally, the number of viable cells at each drug 
concentration was expressed as a percentage relative to that of the non-drug treated 
control. 
2.3 Results 
2.3.1 SW480 is a p-catenin positive cell line 
Anti-P-catenin antibody was successfully optimized with sharp signals and a 
clean background, p-catenin was found to localize in different cellular compartments in 
the two cell lines: nucleus, cytoplasmic and cell membrane expression for SW480, but 
only detected in the cell membrane with a much milder expression in CCD-I8C0 (Figure 
2.3). Based on the ICC staining result, SW480 cell line is confirmed to be a nuclear (3-








































































































































































































































































































2.3.2 Antiproliferative effects of cytotoxic drugs in SW480 cells 
2.3.2.1 5-Fluorouracil 
The SW480 cells were more sensitive to 5-FU than the CCD-I8C0 cells (Figure 
2.4). In SW480 cells, 5-FU resulted in an IC50 value of 16.33±2.11 i^M at 72 hours, 
which is significantly smaller than that of C C D - I 8 C 0 cells (IC50 value of 104.69士8.98 
^M at 72 hours) (Table 2.1). Given the relative sensitivity of SW480 cells to 5-FU, this 
cell line with 16.3 jiM 5-FU treatment for 72 hours was selected for subsequent 
experiments to determine the effect of 5-FU on mRNA and proteins expression in 
SW480 cells. 
Dose response curve of SW480 cells to 5-fluorouracil 
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Figure 2.4 Dose response curve of SW480 and CCD-I8C0 cells to 5-FU. SW480 and CCD-I8C0 
cells were plated on 96-well plates and treated with various concentrations of 5-FU for 0 hours, 
24 hours, 48 hours and 72 hours. Cells viability was determined by MTT assay, and the viable cells 
number was plotted as a percentage of the control (cells not exposed to 5-FU). Each value 
represents the mean 土 SEM of triplicate readings. 
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IC50 value at 72 hours ( _ ) 
Cell line 5-Fluorouracil Oxaplatin Irinotecan 
SW480 16.33±2.11 2.53 ±0.84 16.16±3.15 
CCD-18C0 104.69 土 8.98 - 27.19 士 3.54 
Table 2.1 IC50 values at 72 hours obtained by MTT assays of 5-fluorouracil-, oxaliplatin-, 
and irinotecan-treated SW480 cells and CCD-I8C0 cells. Values were calculated using 




The SW480 cells were more sensitive to oxaliplatin than the CCD-I8C0 cells 
(Figure 2.5). In SW480 cells, oxaliplatin resulted in an IC50 value of 2.53±0.84 at 72 
hours, whereas C C D - I 8 C 0 cells did not reach an IC50 at the concentrations of oxaliplatin 
tested (Table 2.1). 
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Figure 2.5 Dose response curve of SW480 and CCD-I8C0 cells to oxaliplatin. SW480 
and CCD-I8C0 cells were plated on 96-well plates and treated with various 
concentrations of oxalipaltin for 0 hours, 24 hours, 48 hours and 72 hours. Cells viability 
was determined by MTT assay, and the viable cells number was plotted as a percentage 
of the control (cells not exposed to oxaliplatin). Each value represents the mean 土 SEM 




The SW480 cells were more sensitive to irinotecan than the CCD-I8C0 cells 
(Figure 2.6). Irinotecan caused an IC50 value of 16.16士3.15 |iM at 72 hours in SW480 
cells, which is significantly smaller than the value of 27.19土3.54 |j.M at 72 hours in 
CCD-I8C0 cells (Table 2.1). 
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Figure 2.6 Dose response curve of SW480 and CCD-I8C0 cells to irinotecan. SW480 
and CCD-I8C0 cells were plated on 96-well plates and treated with various 
concentrations of irinotecan for 0 hours, 24 hours, 48 hours and 72 hours. Cells viability 
was determined by MTT assay, and the viable cells number was plotted as a percentage 
of the control (cells not exposed to irinotecan). Each value represents the mean 土 SEM 
of triplicate readings. 
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2.4 Discussion 
2.4.1 SW480 as a nuclear p-catenin positive cell line 
The elevated p-catenin signaling is an important event in the genesis of CRC 
(Morin et al, 1997). In the present study, P-catenin immunostaining revealed that 
nuclear P-cateniii was only detected in SW480 cells but not CCD-I8C0 cells. This result 
is consistent with previous literatures that nuclear p-catenin is expressed in CRC cells 
whereas membrane (3-catenin is only expressed in benign colonic epithelial cells (Wong 
et al, 2003). Based on the above observation, SW480 cell line was chosen as a model in 
this study, mainly due to its high expression of nuclear p-catenin, which is a key trigger 
in the dysregulation of the Wnt signaling pathway that plays an important role in the 
evolution of CRC (He et al” 1998). CCD-I8C0 which only showed membrane p-catenin 
expression was used as a control. 
Nuclear p-catenin expression in CRC is important because it provides prognostic 
information to patients with CRC through positive association with lymph node 
metastasis and poor survival. Moreover, together with CK20 immunostaining, nuclear (3-
catenin can differentiate CRC from other CK20 positive tumors (Wong et al, 2003). 
2.4.2 Antiproliferative effects of 5-fluorouracil in SW480 cells 
One of the major chemotherapeutic drugs used to treat CRC is 5-FU. 5-FU is an 
analogue of the pyrimidine uracil, which represents a rationally designed chemotherapy 
agent based on the molecular biology of tumors (Diasio et al., 1989). 5-FU is known to 
exert killing effect by inhibiting proliferation and inducing apoptosis in various CRC 
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cell lines including HCT116 (Borralho et al, 2007), HT-29 (Tang et al, 2007), DLD-1 
(Wang et al, 2003) and RKO (Wang et al, 2003). 
Results of MTT assay showed that 5-FU induced both time and dose dependent 
growth inhibition in both cell lines. As indicated by the IC50 value, SW480 was more 
sensitive to 5-FU than C C D - I 8 C 0 at all concentrations tested. The IC50 value of 5-FU at 
72 hours treatment was 16.3 jiM, hence this time and dose treatment of 5-FU was used 
in subsequent parts to determine the effect of 5-FU on the mRNA and proteins 
expression in SW480. Previous findings showed that the IC50 value at 72 hours 5-FU 
treatment in colon carcinoma cells HT-29 and human CRC cell line SNU-C4 are 
18.4士 1.7 |j.M and 7.1 士0.2 jiM, respectively (Grivicich et al, 2007). Variation is found 
among the IC50 values of 5-FU in different CRC cell lines because the concentration of 
5-FU required to inhibit growth is affected by the culture conditions (e.g. cell density, 
percentage of fetal bovine serum in the medium), time of addition of 5-FU (at the time 
of seeding versus at later time point) and the duration of treatment (Parker et al” 1990). 
2.4.3 Summary 
In this section, we have calculated the IC50 values of 5-FU, oxaliplatin and 
irinotecan after 72 hours treatment in SW480 and C C D - I 8 C 0 cells. In summary, the IC50 
values of 5-FU at 72 hours in both cell lines were found to lie within the range of micro-
I 
molar concentrations, which is higher than the clinical plasma concentration of 5-FU in 
patients (Zheng et al, 2005，Casale et al, 2004). Hence the sensitivity of SW480 cells 
and CCD-I8C0 cells to 5-FU is not very high, therefore other 5-FU sensitive cell lines, 
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such as SNU-C4 and LoVo, should also be included in further study to determine the 
effect of 5-FU on cells viability. 
Based on the results of MTT assay, 5-FU, oxaliplatin and irinotecan induced both time 
and dose dependent growth inhibition in both SW480 and CCD-I8C0 cells. We would 
then carry on examining the effect of 5-FU on the mRNA and proteins expression in 
SW480 cells by Q-RT-PCR arrays and proteomics technologies whereas the effect of 
oxaliplatin and irinotecan in SW480 cells would be examined in future. 
Effect of 5-flrorouracil on mRNA expression in SW480 cells 
Chapter 3 
Effect of 5-fluorouracil on mRNA expression in 
SW480 cells 
3.1 Literature Review 
3.1.1 Application of quantitative real-time polymerase chain reaction in cancer 
research 
3.1.1.1 Principles of quantitative real-time polymerase chain reaction 
Q-RT-PCR is used to monitor the progress of PGR and is designed to collect data 
when the reaction is proceeding. In Q-RT-PCR, reactions are characterized by the time 
when amplification of a target is first detected, which is different from conventional 
PGR that detects the amount of target accumulated after a fixed number of cycles (Real-
Time PGR system Chemistry Guide, Applied Biosystems, 2003). 
SYBR Green chemistry is used to perform Q-RT-PCR analysis in this study. 
SYBR Green is a dye that binds to the minor groove of double-stranded DNA，and can 
be used to detect PCR products which generated during PGR. Since the SYBR Green 
dye can bind to all double-stranded DNA, the result is an increase in fluorescence 
intensity which is proportional to the amount of PCR products produced (Figure 3.1). A 
limitation in using SYBR Green dye is that it may generate false positive signal as it 
binds to any double-stranded DNA, therefore the reaction should be well optimized for 
accurate results (Real-Time PCR system Chemistry Guide, Applied Biosystems, 2003). 
Effect of 5-flrorouracil on mRNA expression in SW480 cells 
The quantitative measurement of Q-RT-PCR was made in terms of threshold 
cycle (Ct), which is the number of cycles required for the sample to reach the threshold 
line. The threshold line is set at the level of detection or at a certain fluorescent intensity 
that the reaction reached above the background. Moreover, the threshold line is being set 
at the exponential phase of amplification for accurate measurement. Therefore，the 
higher the starting copy number of nucleic acid target, the sooner a significant increase 
in fluorescence is observed (Real-Time PGR system Chemistry Guide, Applied 
Biosystems, 2003). 
Effect of 5-flrorouracil on mRNA expression in SW480 cells 
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Figure 3.1 Principles of Q-RT-PCR using SYBR Green dye for the detection of PGR 
products 
(A)Denaturing: Double-stranded DNA helix melts open into two single-stranded DNA 
templates. 
(B)Annealing and Extension: Single-stranded primers anneal to the single-stranded 
DNA template. DNA polymerase extends the sequence-specific primer with the 
incorporation of nucleotides that are complementary to the DNA template, yielding a 
double-stranded DNA complex. 
(C)Fluorescence emission: SYBR Green binds all newly synthesized double-stranded 
DNA complexes and fluoresceses. The fluorescence accumulates as PCR proceed and is 
measured at the end of each PCR cycle. The intensity of fluorescence generated by 
SYBR Green above background level (Ct value) is measured and used to quantitate the 
amount of newly generated double-stranded DNA. 
(Adapted from Sigma-Aldrich online catalogue of SYBR® Green based Quantitative 
PCR, \vw\v.sigmaaldrich.com/img/assets/6600/sybr.gif) 
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3.1.1.2 Advantages of quantitative real-time polymerase chain reaction over 
conventional polymerase chain reaction 
Q-RT-PCR offers several advantages over conventional PGR reaction. First, Q-
RT-PCR measures the increase in reporter fluorescent signal that directly proportional to 
the number of amplicons generated. Second, the Ct value used for quantification in Q-
RT-PCR is measured when the PGR product accumulation is still in the log phase. Third, 
the use of Ct as quantification offers a wider dynamic range, hence reducing the need of 
serial dilution. Finally, Q-RT-PCR runs in a closed tube system and requires no post-
PCR manipulations, therefore the chance of contamination is reduced (Real-Time PGR 
system Chemistry Guide, Applied Biosystems, 2003). 
3.1.1.3 Determination of colorectal cancer biomarkers by quantitative real-time 
polymerase chain reaction 
Previous studies have used Q-RT-PCR to detect possible CRC biomarkers both 
in cell lines and patients' samples. It was reported that treating CRC cell line COL0201 
with 5-FU can induce the mRNA expression of carcinoembryonic antigen (CEA), a 
tumor-associated antigen, and major histocompatibility complex (MHC) class I, a major 
component of the antigen presenting system (Ohtsukasa et al, 2003). Furthermore, it 
was shown that combined treatment of 5-FU with cis-diamminedichloroplatinum(II) 
would give additional effect on CEA expression in COL0201 cells (Ohtsukasa et al, 
2003). These results can show that cancer-specific immunotherapy may be effective 
when used in combination with systemic chemotherapy (Ohtsukasa et al” 2003). 
Effect of 5-flrorouracil on mRNA expression in SW480 cells 
On the other hand, quantification of plasma p-catenin mRNA level by Q-RT-
PCR in CRC patients was conducted, in order to explore the potential of using plasma p-
catenin as a marker for CRC. Results indicated that plasma P-catenin mRNA 
concentration was correlated to tumor stage but not sex, age, lymph node status, and 
degree in differentiation. Moreover, plasma p-catenin mRNA concentration decreased 
significantly after surgical resection in CRC patients (Wong et al, 2003). 
3.2 Materials and Methods 
3.2.1 Determination of the effect of 5-fluorouracil on mRNA expression in SW480 
cells 
3.2.1.1 Treatment of cells 
SW480 cells were seeded in a 100 mm flat-bottom tissue culture plates (BD, 
Franklin Lakes, NJ, USA) and allowed to attach for 24 hours. After attachment, 5-FU 
was dissolved in double distilled water and added to fresh culture medium at a final 
concentration of 16.3 \xM whereas the same volume of autoclaved double distilled water 
was added in control. The cells were incubated for a further 72 hours at 37°C in a 
humidified incubator. After incubation, equal number of cells (2.10x10^) was collected 
from both 5-FU treated and control SW480 cells and they were centrifuged at 1100 ipm 
for 5 minutes. 
3.2.1.2 Extraction of total RNA from SW480 cells 
The pellet was extracted in 1 mL trizol reagent (Invitrogen, Carlsbad, California, 
USA) that can disrupt cells, dissolve cell components and maintain the integrity of RNA. 
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Two hundred microliters chloroform was then added followed by centrifugation at 
12000 g for 15 minutes at 4°C to separate the solution into aqueous and organic phases 
where the RNA remains exclusively in the aqueous phase. 
RNA extraction was continued using the RNeasy mini kit (Qiagen, Hilden， 
Germany). The RNA in the aqueous phase was recovered by adsorption to the 
membrane of the spin column (Qiagen, Hilden, Germany). Binding conditions were 
adjusted with adding equal part of 70% ethanol followed by centrifugation at 8000 g for 
20 seconds. The RNA was washed by centrifugation at 8000 g for 20 seconds using 700 
|iL buffer RWl and 500 iiL buffer RPE consecutively. The remaining ethanol was 
removed by centrifugation at 16000 g for 2 minutes. Finally, the RNA was eluted in 50 
jj,L RNase free water at room temperature, and it was collected and stored at -80°C until 
use. 
3.2.1.3 Removal of genomic DNA 
Removal of genomic DNA was performed by using RNase-Free DNase Set 
(Qiagen, Hilden, Germany). In brief, 50 |iL RNA was mixed with 20 |iL buffer RDD, 5 
|iL DNase I and 125 [iL RNase free water. The mixture was incubated at room 
temperature for 13 minutes. The DNase I-treated RNA was cleaned up using the RNeasy 
mini kit (Qiagen, Hilden, Germany). In brief, 350 \lL of buffer RLT followed by 250 |iL 
absolute ethanol was added to the mixture, which was then transferred to a RNase Mini 
spin column followed by centrifugation at 8000 g for 15 seconds. Five hundred 
microliters of buffer RPE was added to wash the sample by centrifugation for 15 
seconds and 2 minutes consecutively. After that, the spin column with the RNA was 
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placed on an empty collection tube and centrifuged at 16000 g for 2 minutes to avoid the 
carry over of ethanol. Finally, the RNA was eluted with 50 [iL RNase-free water by 
standing at room temperature for 5 minutes followed by centrifugation at 16000 g for 2 
minutes. 
3.2.1.4 Determination of the efficiency of genomic DNA removal 
The efficiency of genomic DNA removal was determined by using Taqman (3-
actin Control Reagents Kit (Pait#401846, Applied Biosystems, Foster City, CA, USA). 
In brief, 1 jiL template was made up to a 50 [lL reaction mixture with 25 [iL 2X PCR 
master mix, 5 |jL forward primer, 5 }iL reverse primer, 5 [lL probe and 9 pL RNase-free 
water. Q-PCR was then performed at 50°C for 2 minutes and 95°C for 10 minutes, 
followed by a 40 cycles of 2-steps reaction (95°C for 15 seconds and 60°C for 1 minute). 
3.2.1.5 Determination of the purity and concentration of RNA 
RNA concentration was determined by measuring the absorbance at a 
wavelength of 260 nm in DU650 Spectrophotometer (Beckman Coulter, Fullerton, 
California, USA). A 70-fold dilution of RNA was prepared by mixing 1 |iL of RNA with 
69 |iL of 10 mM RNase-free Tris pH 8.0 buffer for OD measurement. Each sample was 
measured for 3 times and an average reading at 260 nm (OD260) was obtained for the 
calculation of RNA concentration. 
RNA concentration was calculated as follows: 
RNA concentration (|ig/jj.L) = average OD260 x dilution factor x 40* 
1000 
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*An OD260 reading of 1 corresponds to 40 |ig/mL RNA 
The purity of RNA samples in terms of protein contamination were determined 
by the ratio between the readings at 260 nm and 280 nm (OD260/OD280), whereas the 
purity of RNA samples in terms of salt contamination were determined by the ratio 
between the readings at 260 nm and 230 nm (OD260/OD230). 
3.2.1.6 Determination of the integrity of RNA 
The integrity of RNA was determined by denaturing agarose gel electrophoresis, 
ill which 2 jiL of RNA sample was mixed with 8 i^L of sample loading buffer (13% lOX 
• MOPS (0.2 M MOPS, 0.05 M sodium acetate, 0.01 M EDTA in DEPC-H2O, pH 7), 
23% 12.3 M formaldehyde, 64% formamide and trace amount of ethidium bromide) and 
denatured at 55°C for 15 minutes. The samples were then analyzed by running in a 1.5% 
denaturing agarose gel (0.6 g agarose, 10% lOX MOPS, 7% formaldehyde and 73% 
DEPC-H2O) with IX MOPS (10% lOX MOPS, 90% DEPC-H2O) running buffer. 
Electrophoresis was carried out at 100 V for 30 minutes. The selection criteria for 
samples for the RT^ Profiler飞从 PGR array experiments (APH-028; SuperArray 
Bioscience Corporation, Frederick, MD, USA) were: (1) total RNA was visualized in 
two distinct bands on the RNA gel; (2) the OD260/OD280 ratio was greater than 2.0; (3) 
the OD260/OD230 ratio was greater than 1.7; and (4) the concentration based on OD260 
was greater than 4 ^ig/ml total RNA. 
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3.2.1.7 First strand cDNA synthesis 
First Strand cDNA synthesis was performed using Reaction Ready First strand 
cDNA Synthesis Kit (#C-01, SuperArray Bioscience Corporation, Frederick, MD, USA) 
according to the user's manual (Part#1017A, version 1.5; SuperArray Bioscience 
Corporation, Frederick, MD, USA). In brief, 2 |ig RNA was mixed with 1 |iL Buffer P. 
The mixture was then rounded up to a final volume of 10 [iL with RNase-free water. The 
contents were mixed gently and briefly centrifuged, followed by placing into a 96-well 
programmable thermal cycler (GeneAmp® PCR system 9700, N8050200, Applied 
Biosystems, Foster City, California, USA) at 70�C for 3 minutes and 37°C for 10 
minutes. Ten microliters RT cocktail (4 |iL 5X RT buffer, 4 |jL RNase-free water, 1 |iL 
RNase inhibitor, 1 ^ iL Reverse Transcriptase) was warmed at 37°C for 1 minute and then 
added to each of the above 10 joL annealing mixture. The mixture was then incubated at 
37°C for 60 minutes, followed by 95°C for 5 minutes to degrade the RNA and to 
inactivate the reverse transcriptase. Finally, each 20 [iL of cDNA synthesis reaction 
mixture was diluted by 80 pL of RNase-free water for the subsequent Q-PCR reaction. 
3.2.1.8 Real-time polymerase chain reaction using human Wnt signaling 
pathway RT^ Profiler™ PCR array 
Q-PCR was performed according to the user's manual (Pait#1017A, version 1.5; 
SuperArray Bioscience Corporation). Products from the first strand cDNA synthesis 
reaction were mixed with RT^ PCR master mix with SYBR Green fluorescent dye for 
real-time detection. In brief, 98 \iL diluted first strand cDNA synthesis reaction was 
mixed with 1225 |iL 2X SuperArray PCR master mix and 1127 |iL RNase-free water. 
‘ -44-
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After that, 25 iiL of the reaction mixture was added to each well of the array, which 
contains pre-dispensed gene-specific primer sets. The corresponding genes are from 
several families related to Wnt-mediated signal transduction. These include genes that 
involved in protein modification, intracellular signal molecules, extracellular signaling 
molecules, proteins involved in cell regulation and proliferation, cell surface receptors, 
and regulators. On the other hand, 5 housekeeping control genes were included in the 
array for normalization. Q-PCR detection was performed at 95°C for 10 minutes 
followed by a 40 cycles of 2-steps reaction (95°C for 15 seconds and 60°C for 1 minute). 
A default melting curve program was performed at 95°C for 15 seconds, 60°C for 1 
minute and 95°C for 15 seconds. Finally, the threshold cycle (Ct) for each well was 
recorded. 
3.2.1.9 Calculation of the fold-change in genes expression between the 5-FU treated 
and control SW480 cells 
The Ct value after normalization for each of the gene was calculated as follows: 
For the control SW480 cells: 
ACt (control) = Ct of each gene - average of housekeeping genes' Ct for the 
control array* 
For the 5-FU treated SW480 cells: 
ACt (5-FU treated) = Q of each gene — average of housekeeping genes' Q 
for the 5-FU treated array* 
*The average Ct value for the housekeeping genes is only valid if the difference in the 
average values between the control and 5-FU treated group was less than one cycle 
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The difference of Ct value between the 5-FU treated and control group was then 
calculated as follows: 
AACt = ACt (5-FU treated) - AQ (control) 
The fold-change for each gene of the 5-FU treated and control group was 
calculated as (-AACt). If the fold-change is greater than 1, the result was reported as 
the fold-change for upregulatioii. If the fold-change is less than 1，the negative inverse of 
the result was reported as the fold-change for dowiiregulation. 
3.3 Results 
3.3.1 The quality and quantity of RNA 
The RNA concentrations of the 5-FU treated and untreated SW480 cells were 
calculated as described in section 3.2.1.5. The concentrations of RNA in 5-FU treated 
and untreated SW480 cells are 0.7708 \ig/\iL and 3.0134 [Lg/\iU respectively. The 
OD260/OD280 ratio is 2.1 whereas the OD260/OD230 ratio is 2.0 for both 5-FU treated 
and untreated SW480 cells. Two distinct bands are shown in the gel photo by gel 
electrophoresis (Figure 3.2). The above results indicated that the extracted RNA samples 
were free of proteins and salts contaminants and were of good quantity and quality for 
performing RT" Profiler™ PGR array. 
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Figure 3.2 Demonstration of total RNA quality by denaturing agarose 
gel electrophoresis 
SW480 cells were treated with 16.3uM of 5-FU for 72 hours in the 5-FU 
treated setup or without treatment of 5-FU in the control setup. RNA was 
extracted from the 5-FU treated and untreated SW480 cells. Two 
microliters of denatured RNA sample was analyzed by running in a 
1.5% denaturing agarose gel at 100 V for 30 minutes. The lane on the 
left is the RNA sample extracted from untreated SW480 cells. The lane 
on the right is the RNA sample extracted from 5-FU treated SW480 cells. 
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3.3.2 Effects of 5-fluorouracil on genes expression in SW480 cells 
The Ct value for each gene in both 5-FU treated and non-treated SW480 cells 
were determined and compared to obtain the fold change in gene expression after drug 
treatment. The method for calculation of fold-change was indicated in section 3.2.1.9. 
Fifty-eight out of 84 genes in the arrays had shown an increase in expression 
after 5-FU treatment, in which 13 genes showed a more than two-fold expression 
difference. These differential expressed genes include frizzled-related protein (FRZB), 
dickkopf homolog 1 (DKKl), Wnt-9A, FOS-like antigen 1 (FOSLl), porcupine 
(PORCN) homolog, Myc, dishevelled dsh homolog 1 (DVLl), frequently rearranged in 
advanced T-cell lymphomas (FRAT), Jun oncogene, APC, paired-like homeodomain 
transcription factor 2 (PITX2), cyclin D3 and B-cell CLL/ lymphoma 9 (Bcl-9) (Table 
3.1) (Figure 3.3). 
Besides, 17 genes showed a decrease in expression after 5-FU treatment in 
SW480 cells, in which 3 genes showed a more than two-fold expression difference. 
These differential expressed genes include sex determining region Y-box 17 (S0X17), 
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3.4 Discussion 
3.4.1 Alterations in mRNA expression in 5-fluorouracil treated SW480 cells 
The expression of various genes related to Wnt-mediated signal transduction 
using Q-RT-PCR arrays varied significantly in SW480 cells after treatment with 16.3jj.M 
5-FU for 72 hours. Those differential expressed genes with at least 2-fold change are 
potential 5-FU response genes. We divided these differential expressed genes into 
several groups, including extracellular signaling molecules, members of canonical Wnt 
signaling pathway, regulators of cell cycle，regulators of growth and proliferation, 
regulators of transcription, regulators of Wnt receptor signaling pathway and other genes 
involved in Wnt signaling. A description on those genes is shown below. 
3.4.1.1 Extracellular signaling molecules 
In the present study, the differentially expressed extracellular signaling 
molecules belong to the Wnt proteins family, which represent a family of secreted 
signaling molecules that are expressed in diverse tissues and have been shown to 
regulate cell proliferation, growth and differentiation (Peifer et al” 2000). Our results 
showed that the expression of Wnt-9A increased in 5-FU treated SW480 cells, whereas 
the expression of Wnt-11 and Wnt-2 decreased in 5-FU treated SW480 cells. 
Wnt-2 mRNA is frequently up-regulated in CRC and gastric cancer (Katoh et al., 
2001). From our results, Wnt-2 is one of the few genes which showed a decreased 
expression after 5-FU treatment in SW480 cells. Previous studies stated that siRNA 
silencing of Wnt-2 expression inhibited Tcf-repoiler activity, decreased cytosolic j3-
catenin expression and induced apoptosis in CRC cells (Shi et al, 2007). However, the 
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significance of Wnt-2 down-regulation in CRC remains contradictory and further study 
is required (Shi et al, 2007). 
Other Wnt proteins, including Wnt-9A and Wnt-11, are involved in various 
functions. Wnt-9A stimulates |3-catenin-responsive transcription and promotes cell 
proliferation in cardiac atrioventricular canal cells (Person et al, 2005). Moreover, 
overexpression of Wnt-9A inhibits cell proliferation in breast MCF-7 tumor cells, 
whereas the inhibition of Wnt-9A expression by siRNA can restore cell proliferation 
(Xiang et al, 2007). The increased Wnt-9A expression observed in this study is 
hypothesized to inhibit cell proliferation in SW480 cells. 
Finally, Wnt-11 expression is elevated in hormone-independent prostate cancer 
cell lines, high-grade prostatic tumors and in hormone-independent xenografts (Zhu et 
al, 2004). The function of Wnt-11 is to inhibit androgen receptor transcriptional activity 
and cell growth in androgen-dependent cells. Moreover, Wnt-11 can also inhibit the 
activation of the canonical Wnt pathway in HEK293 cells and (3-catenin/Tcf 
transcriptional activity in LNCaP cells (Zhu et al, 2004). On the other hand, Wnt-11 can 
work with frizzled receptor 7 which this complex can recruit Dishevelled and the 
consequence is to increase in cell contact persistence and coordination of cell 
movements (Witzel et al, 2006). 
3.4.1.2 Canonical Wnt signaling pathway 
Canonical Wnt signaling regulates the transcription of Tcf/Lef-mediated genes 
through the stability of p-cateniii, and may contribute to the regulation of drug 
sensitivity observed in various cell lines (Moon et al” 2002). In this study, members of 
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canonical Wnt signaling pathway, DVLl, showed an increased expression in SW480 
cells after 5-FU treatment. 
DVL is responsible for regulating the dominance of either canonical or non-
canonical Wnt pathways. The canonical Wnt signaling pathway refers to the regulation 
of transcription through the APC/GSK-3p/axin complex, whereas the non-canonical Wnt 
signaling pathway refers to either the Jun NH2-terminal kinase (JNK) pathway or the 
Ca"^-releasing pathway (Wodarz et al, 2001). The increase in DVL expression can be 
achieved by CKI phosphorylation, in which phosphorylated DVL switch the Wnt 
signaling towards the canonical pathway (McKay et al, 2001). 
3.4.1.3 Regulators of cell cycle 
In this study, Wnt signaling pathway-related genes, APC and cyclin D3, which 
involved in the regulation of cell cycle, showed an increased expression after 5-FU 
treatment in SW480 cells. Their functions are discussed as follows. 
APC is an important tumor suppressor for CRC, which acts as an essential 
component of p-catenin signaling pathway and plays a key role in intestinal homeostasis 
and CRC (Polakis et al, 2000). Research has correlated different APC mutations with 
colon cancer phenotype and also point out that mutated APC is required for cell 
proliferation (Yang et al., 2006). In this study, the expression of APC increased in 5-FU 
treated SW480 cells, comparing to the non-treated controls. The increase in APC 
expression was also detected in previous experiments which CRC cell lines were treated 
with protein synthesis inhibitor cycloheximide (Jaiswal et al” 1999) and sulindac, 
respectively (Schnitzler et al, 1996). 
Effect of 5-fluQrouracil on proteins expression in SW480 cells 
Cyclin D3, a member of the cyclin D family, is one of the Wnt signaling pathway 
targeted genes. Cyclin D3 regulates the initial G1 to S transition in the cell cycle, hence 
contributes in cell apoptosis, proliferation and differentiation (Borgne et al, 2003). In 
addition, cyclin D3 is overexpressed in a number of human cancers, including breast 
carcinomas (Janicke et al, 1996)，B cell and T cell malignancies (Boonen et al, 1999). 
3.4.1.4 Regulators of growth and proliferation 
Array results from this study also indicated that Wnt signaling pathway-related 
gene FRAT, which involved in regulation of growth and proliferation, showed an 
increased expression after 5-FU treatment in SW480 cells. 
It was reported that FRAT, a GSK-Sp inhibitory protein, can interact with DVL. 
Following Wnt stimulation, FRAT caused the disassociation of GSK-3j3 from axin, 
therefore cytosolic levels of P-catenin would accumulate and (3-catenin can then 
translocate to the nucleus (Fraser et al, 2002). 
3.4.1.5 Regulators of transcription 
Wnt signaling pathway-related genes involved in regulation of transcription, 
including Myc, Jun oncogene, PITX2 and FOSLl, showed an increased expression after 
5-FU treatment in SW480 cells, whereas the expression of S0X17 decreased after 5-FU 
treatment in SW480 cells. Their descriptions are as follows. 
The myc oncogene encodes for transcriptional factors involved in many cellular 
processes such as proliferation, differentiation and apoptosis (Prendergast et al, 1999， 
Nilsson et al, 2003). Myc is frequently overexpressed in many human tumors, including 
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CRC (Nilsson et al, 2003). The increased expression of myc may contribute to drug 
sensitivity in SW480 cells. This hypothesis is explored and found that decreased myc 
expression can improve vinblastine sensitivity in CRC cell line LoVo and triggers earlier 
apoptosis through induction of the intrinsic pathway. Therefore myc induction may act 
as a resistant factor to vinblastine treatment (Bressin et al, 2006). 
The expression of jun oncogene was found to increase in 5-FU treated SW480 
cells in this study. To our laiowledge, no literature has ever suggested the direct role of 
jun oncogene in the regulation of 5-FU sensitivity. However, the JNK cascade, which 
phosphorylates Jun proteins，was widely studied for its role in drug-induced apoptosis 
(Stone et al, 2000, Hua et al, 2006). Moreover, recent evidence has also showed that 
JNK played an important role in curcuniin-mediated apoptosis in human CRC cells 
(Collett et al, 2004). 
PITX2 is one of the known (3-catenin/Lef-mediated transcriptional targets. 
Previous study has revealed that stress conditions will cause an increased nuclear p-
catenin/Lef-1 expression as well as c-Myc, cyclin Dl, and PITX2 in skeletal muscle 
cells (Armstrong et al, 2005). 
Recent study has identified FOSLl as a target of Wnt signaling pathway (Abe et 
al, 2007). The members of the Fos protein family are subdivided in two groups, 
according to their ability to transform rodent fibroblasts, transforming and non-
transforming proteins (Abe et al, 2007). Members of the two groups are differentially 
activated in response to external stimuli and possess different structural features. 
Member of the non-transfomiing group are weak transcriptional activators and are found 
to dimerize with Jun protein (Tulchinsky 2000). 
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The high-mobility-group DNA-binding domain (HMG box) transcription factor 
SOX 17 is a key component of vertebrate gastrulation pathway and is essential for 
endoderm formation. In normal gastrointestinal tract, S0X17 mRNA is preferentially 
expressed in esophagus, stomach and small intestine (Katoh 2002). Besides, recent study 
has also revealed the location of binding motif in SOX 17 to p-catenin, which is required 
for SOX 17 to activate the transcription of p-catenin target genes (Sinner et al, 2004). 
3.4.1.6 Regulators of Wnt receptor signaling pathway 
Genes involved in regulation of Wnt signaling pathway, including DKKl and 
FRZB, showed increased expressions after 5-FU treatment in SW480 cells. 
DKKl inhibits Wnt signaling by binding to LRP5/6. The DKK-LRP5/6 
interaction alters the conformation of LRP5/6 so that it can no longer interact with Wnt, 
therefore causing inhibition of the Wnt signaling pathway (Mao et al, 2001). The 
increased expression of DKKl observed in SW480 cells after 5-FU treatment is 
hypothesized to inhibit Wnt signaling pathway, which may affect the transcription of 
genes regulating 5-FU sensitivity. 
FRZB is another antagonist that binds directly to Wnt, therefore preventing their 
binding to receptors. FRZB comprises an N-terminal domain homologous to the 
cysteine-rich domain (CRD) of the frizzled family of Wnt receptors (Mehien et al,, 
1998). The CRD domains of the FRZB will compete with the frizzled receptors for Wnt 
binding and hence modulating the Wnt signal (Crundwell et al., 1996) by decreasing the 
cytoplasmic and nuclear expression of p-catenin (Suzuki et al., 2004). 
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3.4.1.7 Other genes involved in Wnt signaling 
Apart from the above mentioned genes, there are other genes involved in Wnt 
signaling pathway. Examples of these genes which showed an increased expression after 
5-FU treatment in SW480 cells are PORCN homolog and Bcl-9. These Wnt related 
genes may exert their effects on gene transcription and drug-induced apoptosis that 
affect the regulation of 5-FU sensitivity. 
Bcl-9 and a Bcl-9-like protein, B9L，are involved in the regulation of 
transcription avtivity of p-cateniii/Tcf complex. Bcl-9 is required for enhanced (3-
cateniii/Tcf-mediated transcription in CRC cells (Adachi et al, 2004). Furthermore, 
expression of B9L was elevated in about 43% of colorectal tumors. These results 
suggest that Bcl-9 together with B9L plays an important role in tumorigenesis induced 
by aberrant activation of Wnt signaling pathway (Adachi et al, 2004). Recent study has 
proposed that the p-cateniii binding site of Bcl-9 forms a good target for developing 
drugs that block canonical Wnt/p-catenin signaling (Sampietro et al, 2006). 
Finally, PORCN gene homologs encode the human homolog of Drosophila 
melanogaster porcupine which is an endoplasmic reticulum protein involved in secretion 
of Wnt proteins (Wang et al, 2007). Researchers have also found that the expression of 
PORCN in multiple tissues can influence the activity of Wnt-7A expression (Caricasole 
et al, 2002). 
3.4.2 Limitations of Q-RT-PCR 
Q-RT-PCR array used in this study contained pre-dispensed gene-specific primer 
sets related to Wnt signaling pathway, therefore the global mRNA expression pattern 
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maybe overlooked. Besides, SYBR Green dye can bind to all double-stranded DNA, 
which may generate false positive signals, and the reaction should be well optimized 
(Real-Time PCR system Chemistry Guide, Applied Biosystems, 2003). Moreover, RNA 
/ 
is extremely unstable compared with DNA, therefore isolation of it must be carefully 
performed to ensure the integrity of RNA and the removal of contaminating nucleases, 
genomic DNA, and inhibitors. Finally, laboratory equipment, such as pipettes and bench 
top area, should also be kept clean for Q-RT-PCR use in order to increase the 
reproducibility of the experiment (Real-Time PCR system Chemistry Guide, Applied 
Biosystems, 2003). 
3.4.3 Summary 
In conclusion, we have detected a number of potential 5-FU response Wnt 
signaling pathway related genes using Q-RT-PCR arrays. The results are novel but 
preliminary. Therefore, we would validate them in other 5-FU sensitive and resistant 
CRC cell lines in future. 
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Chapter 4 
Effect of 5-fluorouracil on proteins expression in 
SW480 cells 
4.1 Literature Review 
4.1.1 From mRNA to proteins 
Understanding the molecular mechanisms of 5-FU on SW480 cells is 
fundamental to the rational development of markers indicating the effectiveness of 
this drug. Therefore the study of mRNA and protein expression patterns would make 
important contribution to this understanding. As a consequence, we continue to study 
the effect of 5-FU in SW480 cells using proteomics technology after using 
Q-RT-PCR arrays in order to study the effect of 5-FU on the protein profiling. 
4.1.2 Application of proteomics in cancer research 
Proteomics is the study of global proteins expression patterns in cells and 
tissues which deals with large-scale determination of genes and cellular functions 
directly at protein level. The most common technique in proteomics is the 
combination of two-dimensional gel electrophoresis (2-DE) and mass spectrometry 
(MS) (Mann et al., 2001). In brief, proteins mixtures are separated by 2-DE and the 
proteins, after silver staining, are quantified by their staining intensities. Differential 
protein spots are selected for excision, digestion and identification by MS (Katayama 
et al, 2001). 
Recent improvements in 2-DE, image analysis, MS, and the development of 
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advanced bioinformatics databases and analysis software, have enabled the 
proteomics technology to identify disease-associated protein markers that are helpful 
in diagnosis or prognosis (Wulfkuhle et aL, 2003). Currently, there is a growing body 
of evidence revealing the great potential of proteomics technology in the analysis of 
response and resistance of tumor cells to cytotoxic drugs (Urbaiii et al” 2005). 
4.1.3 Two-dimensional gel electrophoresis 
During 2-DE process, proteins are separated by their charges in the first 
dimension and then by size in the second dimension. Recent developments in 
employing immobilized pH gradient (IPG) strips as the first dimension has produced 
significant improvement in 2-DE separation that enables higher resolution and 
greater reproducibility. Moreover, it allows effective separation of complex 
proteomes including human cancer cells, and facilitates subsequent spots 
identification by peptide mass fingerprint (PMF) and MALDI TOF MS (Zhang et al., 
2005). 
4.1.4 Principles of MALDI TOF mass spectrometry 
Protein identification is the most important step in expression proteomics which 
is made possible by the discovery of protein ionization methods. MALDI is the most 
common ion-producing method as it allows a higher sample throughput. Therefore 
several proteins can be analyzed simultaneously in a single experiment (Aebersold et 
al., 2003). MALDI ionization is a technique in which proteins are co-crystallized 
with an acidified matrix. The matrix is a small molecule, which normally absorbed 
ultraviolet light and dissipates the absorbed energy thermally (Aebersold et aL, 2003). 
The most common matrix are 3,5-dimethoxy-4-hydroxyciiinamic acid (DHA), 
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a-cyano-4-hydroxycimiamic acid (CHCA) and 2,5-dihydroxybenzoic acid (DHB). 
The matrix together with analyte molecules are then mixed with another organic 
compound, acetonitrile (ACN) or ethanol, and purified water. The organic compound 
allows the hydrophobic proteins in the sample to dissolve into the solution, whereas 
the water allows the hydrophilic proteins to disslove (Karas et al., 1988). 
The analyte and matrix molecules are inserted into a vacuum chamber of the 
mass spectrometer. The analysis of peptide masses is initiated by a pulsed laser beam 
which transfers high amounts of energy into the matrix molecules. The energy 
transfer is sufficient to promote the transition of matrix molecules and peptides from 
solid state into gaseous state. The molecules are then accelerated in the electric field 
of the mass spectrometer and are flied towards an ion detector where the molecules 
are detected as an electric signal. Their masses are proportional to their TOF in the 
drift tube and can be calculated accordingly. 
4.1.5 Peptide mass fingerprinting 
PMF is used to identify proteins by matching their peptide masses to the 
theoretical peptide masses from a protein database such as SWISSPROT and NCBIiir. 
Since every unique protein will have a unique set of peptides masses, identification 
of proteins can be achieved by matching the observed peptide masses to the 
theoretical masses derived from the protein databases. 
4.1.6 Drug response proteins detected by proteomics in colorectal cancer 
cell lines 
Studies have detected the drug response proteins in SW480 cells using 
proteomics technology. One of these drugs is quercetin, characterized by its phenolic 
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ring structure, belong to a group of plants' chemical components known as 
flavonoids. Quercetin treatment on SW480 cells causes a decreased expression of 
type II cytoskeletal 8 keratin, NADH dehydrogenase and Fe-S protein 3, but an 
increased expression of aiinexin (Mouat et al., 2005). These proteins have been 
identified as the potential molecular targets of quercetin, and this example can 
demonstrate the use of proteomics in the detection of quercetin response proteins in 
SW480 cells. 
4.1.7 Detection of biomarker in colorectal cancer formation using proteomics 
Proteomics can also be used to detect the proteins expression profile in cancer 
formation. Study has identified proteins abundantly expressed in SW480 cells when 
compared with normal colon cell lines. These differential expressed proteins include 
enzymes (e.g. enolase, peptidylprolyl isomerase), cytoskeletal components (e.g. 
intermediate filaments) and immunological molecules (e.g. MHC class I promoter 
binding protein) and they may play a role in colorectal carcinogenesis (Zhang et al., 
2005). 
Other researchers have reported similar findings using CRC clinical 
specimens. In those studies, analysis of proteins extracted from frozen biopsies 
revealed different classes of proteins being differentially expressed in CRC. These 
proteins were mainly involved in cellular reorganization and cytoskeleton (e.g. 
cytokeratin, p-actin), cell communication and signal transduction (e.g. annexins IV 
and V, APC), and protein folding (e.g. heat shock protein 60). 
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4.2 Materials and Methods 
4.2.1 Determination of the effect of 5-fluorouracil on proteins expression in 
SW480 cells 
4.2.1.1 Treatment of cells 
SW480 cells were seeded in a 100 mm flat-bottom tissue culture plates (BD， 
Franklin Lakes, NJ, USA) and allowed to attach for 24 hours. After attachment, 5-FU 
was dissolved in double distilled water and added to fresh culture medium at a final 
concentration of 16.3 |j.M whereas the same volume of autoclaved double distilled 
water was added in controls. The cells were then incubated for a further 72 hours at 
37°C in a humidified incubator. 
4.2.1.2 Cell lysis 
Triplicate experiments from cell lysis to 2-DE were performed. The culture 
medium was discarded and the cells were rinsed with ice-cold isotonic buffer (250 
mM sucrose, 10 mM Tris-HCL, pH 7.2) for 4 times on ice. Lysis buffer composed of 
9 M urea, 4% CHAPS, 10 niM Tris-HCL, 50 mM dithiothreitol (DTT), 0.6% pH 
3-10 NL IPG buffer, Ix Complete protease inhibitor (Roche Diagnostics, Basel, 
Switzerland), pH 8.8 was then added to each culture dish. The cells were scraped 
thoroughly with a scraper and allowed to lyse on ice for 15 minutes. The cell lysates 
were collected and centrifuged at 10000 g for 20 minutes at 4°C to obtain the clear 
supernatant without insoluble cell debris. 
4.2.1.3 Protein quantitation of cell lysate 
The protein concentration of each cell lysate was measured using the RC DC 
Protein Assay (Bio-Rad Laboratories, Hercules, CA, USA). The RC DC Protein 
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Assay is a colorimetric assay for protein quantitation based on the Lowry assay 
(Lowry et al,, 1951) but has been modified to be reducing agent compatible (RC) and 
detergent compatible (DC). Five dilutions of protein standard with concentrations 0 
mg/mL, 0.2 mg/mL, 0.4 mg/mL, 0.8 mg/niL and 1.5 nig/mL were prepared. The 
protein standards and cell lysate were made up to a volume of 25 jjL with double 
distilled water. One hundred and twenty five microliters of RC reagent I was added 
to each tube, mixed by vortexing and incubated at room temperature for 1 minute 
followed by addition of 125 \xL of RC reagent II and it was mixed by vortexing and 
centrifuged at 15000 g for 5 minutes. The supernatant was then discarded and 
replaced by 125 joL of RC reagent I. After incubating at room temperature for 1 
minute, 40 |iL of RC reagent II was added, mixed by gentle inversion and 
centrifuged at 15000 g for 5 minutes. The supernatant was then discarded and 
replaced with 127 |iL of solution A, which was prepared by mixing 2.5 |iL of DC 
reagent S with 125 |JL of Reagent A. The tubes were mixed well by vortexing and 
incubated at room temperature for 5 minutes. One milliliter DC reagent B was added 
and mixed by vortexing followed by incubation at room temperature for a further 15 
minutes. After incubation, 250 \xL of each sample was transferred to a 96-well 
flat-bottom tissue culture plate (BD, Franklin Lakes, NJ, USA). The absorbance of 
each well was determined by SPECTRA Rainbow microplate reader (MTX Lab 
Systems Inc, Vienna, Virginia, USA) at a wavelength of 700 nm. A standard curve 
was plotted by plotting OD against protein concentration. The protein concentration 
in each cell lysate was calculated from the standard curve. 
4.2.1.4 Sample preparation for two-dimensional electrophoresis 
Sample preparation was performed using the R e a d y P r e p T M 
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Reducation-Alkyaltion Kit (Biorad Laboratories, Hercules, CA, USA). Cell lysate 
was added with 9 jiL alkylation buffer and made up to 300 pL with lysis buffer (9 M 
urea, 4% CHAPS, 10 mM Tris-HCL, 50 mM dithiothreitol (DTT), 0.6% pH 3-10 NL 
IPG buffer, Ix Complete protease inhibitor, pH 8.8) to a final protein concentration 
of 1 jig/jiL. The mixture was reduced with 50 mM DTT for 2 hours at 23°C followed 
by alkylation with 150 mM iodoacetaniide at 23°C for a further 2 hours. After that, 
50 mM DTT was added, followed by incubation at 23°C for 15 minutes. The protein 
concentration of the sample was quaiititated as described in section 4.2.1.3, and the 
cell lysates of each cell line were then ready for 2D electrophoresis. 
4.2.1.5 Two-dimensional electrophoresis 
Fifty micrograms of reduced and alkylated proteins from the cell line under 
experimental or control treatment were made up to a volume of 180 jj-L with 
rehydration buffer (9 M Urea, 4% CHAPS, 10 niM Tris-HCL, 50 mM DTT, 0.6% pH 
3-10 NL IPG buffer, pH 8.8). Passive rehydration was performed for 14 hours after 
which isoelectric focusing (lEF) on 11 cm ReadyStrip™ IPG strips (Bio-Rad) with a 
non-linear pH range of 3-10 was performed for 20000 volt-hours. After lEF, the IPG 
strips were incubated with equilibration buffer (6 M Urea, 375 mM Tris-HCL, 20% 
glycerol, 2% sodium dodecyl sulfate (SDS), 2% DTT, pH 8.8) for 30 minutes with 
shaking at room temperature. SDS-polyacrylamide gel electrophoresis (PAGE) was 
then performed for 220 volt-hours in 4% - 12% Bis-Tris Criterion™ XT precast gels 
(Bio-Rad). 
4.2.1.6 Silver staining 
The proteins were fixed in the gel with fixative solution (40% methanol, 10% 
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acetic acid) for 30 minutes and silver staining was then performed using PlusOne™ 
Silver Staining Kit (GE Healthcare Bio-Sciences AB, Uppsala, Sweden). The gel was 
first washed with double distilled water for 15 minutes for 4 times. The fixed 
proteins were sensitized for staining with sensitizing solution (30% ethanol, 6.8% 
sodium acetate, 4% sodium thiosulphate) for 30 minutes at room temperature with 
shaking. The sensitizing solution was removed and the gel was then washed with 
double distilled water for 5 minutes thrice. Silver solution (10% silver nitrate) was 
added and incubated at room temperature for 20 minutes with shaking. The silver 
solution was then removed and the gel was washed with double distilled water for 1 
minute twice. The staining pattern of the gel was developed by incubation with 
developing solution (2.5% sodium carbonate, 0.0067% formaldehyde) at room 
temperature with shaking for 7 minutes. The developing solution was removed, and 
stain development was stopped by incubation with stopping solution (1.46% 
EDTA-Na2.2H20) at room temperature with shaking for 10 minutes. The stopping 
solution was removed and the gel was then washed with double distilled water for 5 
minutes thrice and was preserved in double distilled water at 4°C. 
4.2.1.7 Image analysis 
The stained gels were scanned using Model GS-700 Imaging Densitometer 
(Bio-Rad) and analyzed using PDQuest™ 2D analysis software (Bio-Rad). Total 
intensity in valid spots was used as the normalization method in the analysis. Spots 
differed by 2-fold or more was considered as proteins with differential expression. 
4.2.1.8 In-gel protein digestion 
Fourteen differentially expressed protein spots with highest fold change were 
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Effect of 5-fluorouracil on proteins expression in SW480 cells 
selected for protein identification. The selected spots were excised from the gel and 
transferred to siliconized tubes pre-rinsed with 50% ACN, 40% methanol, and 0.1% 
trifluoroacetic acid (TFA). The gel spots excised from the gels were incubated with 
500 jj-L SDS removal solution (85% acetone, 5% acetic acid, 5% triethylamine, 5% 
milli-Q water) for 1 hour at 4°C with shaking, the solution was then discarded and 
the gel spots were dried at 37°C for 5 minutes. After SDS removal, the silver stain 
was removed by incubating the gel spots with 50 jiL freshly prepared silver 
destaining solution (15 inM potassium ferricyaiiide and 50 mM sodium thiosulfate) 
for 3 minutes with shaking. The silver destaining solution was then discarded and the 
gel spots were washed with 50 |iL milli-Q water for 3 minutes thrice. After that, the 
gel spots were incubated with 50 jiL of 200 mM NH4HCO3 with shaking for 20 
minutes. The solution was then discarded, followed by washing the gel spots with 50 
JJL milli-Q water for 1 minute with shaking. Finally, the gel spots were dehydrated 
with 50 |iL ACN for 1 minute with shaking thrice and then dried at 37°C for 5 
minutes. The gel pieces were then incubated with a trypsin solution containing 25 
Hg/mL sequencing-grade trypsin (Promega Corporation, Madison, WI, USA) with 40 
mM ammonium bicarbonate and 10% ACN. Trypsin digestion was allowed to 
proceed at 37°C for 15 hours and peptides were harvested with 20 ^L of 1% TFA 
solution (aqueous extraction) twice followed by 20 [iL of ACN solution (organic 
extraction) twice. The harvested peptides from the organic extraction were dried 
under vacuum at 40°C for 30 minutes, followed by redissolving in peptides harvested 
from the aqueous extraction. 
4.2.1.9 Peptide mass fingerprinting using mass spectrometry 
Peptides were purified using ZipTip™ CI8 microcolumns (Millipore 
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Corporation, Billerica, MA, USA) and eluted in 2 solution containing 80% ACN 
and 0.1% TFA. The eluted peptides were then spotted onto a 400-spot Teflon-coated 
sample plate (Applied Biosystems, Foster City, CA, USA) with CHCA as matrix 
using the "Sandwich Method". For each peptide sample, 0.3 iiL of 0.625 mg/iiiL 
CHCA dissolved in 50% ACN, 40% MeOH and 0.1% TFA was first added to the 
sample plate and dried. After that, the sample was repeatedly applied to the same 
sample well in 0.3 \iL fractions each time with vacuum drying after each successive 
addition. After the entire sample was transferred, 0.3 \xL of 0.625 mg/mL CHCA was 
added again followed by vacuum drying. Samples were then irradiated with laser at 
337 nm using Voyager DE™ - Pro (Applied Biosystems) in reflector mode with 
external calibration using Sequazyme™ Peptide Mass Standards kit (Applied 
Biosystems) and mass spectra were acquired. Monoisotopic mass values from the 
spectra were submitted to the Aldente (http://www.expasy.org/tools/aldente/) and 
Mascot (http://www.matrixscience.com/) search engines and searched against the 
National Center for Biotechnology Information (NCBI) and Swiss-Prot human 
protein database for protein identification. 
4.3 Results 
4.3.1 Protein expression patterns of 5-fluorouracil treated and untreated 
SW480 cells by 2-dimensional electrophoresis 
To determine the changes in protein expression patterns of SW480 after 5-FU 
treatment, comparative 2-DE and image analysis between 5-FU treated (72 hours 
duration at 16.3 |J-M dosage) and untreated SW480 cells were performed (Figure 4.1). 
The 2-DE patterns between the 5-FU treated and untreated cells were compared 
using PDQuest software which detected 204 proteins with at least 2-fold differential 
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4.3.2 Identification of the differentially expressed proteins after 5-fluorouracil 
treatment in SW480 cells 
Among the differentially expressed proteins, 6 upregulated protein spots and 
8 downregulated protein spots were excised from the silver-stained gels and digested 
by trypsin followed by proteins identification using MALDI-TOF MS. Identified 
upregulated proteins were cyclophilin A (2.8 fold), cytokeratin 19 (CKI9) (2.8 fold), 
cytokeratin 8 (CK8) (4.5 fold), ras-related nuclear protein (RAN) (5.3 fold), heat 
shock protein 27 (hsp27) (8.6 fold) and peroxiredoxin 6 (Prx 6) (10.9 fold) (Figure 
4.2) (Table 4.1). Downregulated proteins include heat shock protein 60 (hsp60) (3.2 
fold), cytokeratin 18 (CKI8) (3.6 fold), cytokeratin 9 (CK9) (4.0 fold), 
carbamoylphosphate synthetase I (CPSl) (4.0 fold), a-enolase (ENOl) (4.2 fold), 
heat shock protein 70 (hsp70) (8.9 fold), mn23 (5.9 fold) and p-actin protein (10.0 
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4.4 Discussion 
4.4.1 Effects of 5-fluorouracil on protein expression in SW480 cells 
Recent advancements in proteomics profiling technologies has enabled us to 
take a comprehensive approach towards characterization of molecular events that 
predict treatment of cells with 5-FU. This study used state-of-the-art proteomics 
technologies, 2-DE followed by MALDI-TOF MS, to perform a global analysis in 
order to identify molecular targets of 5-FU in a CRC cell line SW480, which is a 
nuclear P-catenin positive cell line. 
Early detection of 5-FU response proteins would greatly enhance the 
effectiveness of treatment strategies because CRC patients with no response to 5-FU 
can change to another chemotherapeutic drug promptly. In the past, research at the 
protein level was hampered by the complexity of the proteome. Rapid development 
of the proteomic technologies integrated with advanced bioinformatics tools in recent 
years has changed the situation that allows comparison of thousands of proteins 
simultaneously. In this study, the change in proteins expression in a CRC cell line 
SW480 to 5-FU treatment was studied using 2-DE and the identity of proteins was 
examined using MS. Out of 204 proteins with at least 2-fold differential expression, 
6 upregulated and 8 downregulated proteins were selected and successfully identified 
which belong to various families with different functions including cytoskeleton 
(CKl9，CK8, CKl 8，CK9 and P-actin), molecular chaperones (hsp27, hsp60 and 
hsp70), peptidyl-prolyl isomerase (cyclophilin A), GTPase (RAN), anti-oxidant 
enzyme (Prx 6), urea cycle enzyme (CPS I), glycolytic enzyme (ENOl) and 
nucleoside diphosphate kinase (iini23). 
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4.4.1.1 Identified upregulated proteins after 5-fluorouracil treatment in 
SW480 cells 
4.4.1.1.1 Cyclophilin A 
Cyclophilin A is a protein that possesses peptidyl-prolyl isomerase activity 
(Shaw et al, 2002). Besides, it is essential for T-cell activation and can form strong 
interactions with HIV-1 gag proteins (Luban et al., 1993). It is implicated in many 
cellular processes including trafficking, signal transduction, cell cycle regulation, 
differentiation, transcriptional regulation and stabilization of multiprotein complexes 
(Galat et aL, 2003). Cyclophilin A is reported to be overexpressed in CRC, small-cell 
lung cancer and pancreatic cancer (Melle et al.’ 2005). 
4.4.1.1.2 Cytokeratin 19 
CK19 is a member of the family of intermediate filaments which is expressed 
in all epithelial cells including pancreatic islet cells from 12 to 16 weeks of fetal 
development. Thereafter, its expression decreases and eventually disappears from 
most islet cells but remains strong in pancreatic ductal cells (Bouwens et aL, 1997). 
Recent study has indicated that CK19 is a powerful predictor of survival in 
pancreatic endocrine tumors and is helpful in the differential diagnosis of true 
papillary carcinoma of thyroid and papillary carcinoma-like changes in Graves' 
disease (Erkilic et al,, 2005). On the other hand, circulating CK19 protein or mRNA 
fragments has been used as a prognostic marker in non-small cell lung cancer (Pujol 
et al., 1996), breast cancer (Inokuchi et al., 2003), and liver cancer (Uenishi et aL, 
2003). 
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4.4.1.1.3 Cytokeratin 8 
CK8 is not expressed in healthy epithelium except a weak expression in liver 
and heart (Gires et al, 2005). During mitosis, membrane CK8 can exhibit a 
re-distribution intracellularly by undergoing phosphorylation at serine 73 and it 
relocates to the plasma membrane of the cancer cells that represents a valuable target 
for anti-cancer therapy (Ku et al, 2002). CK8 is homogeneously expressed in head 
and neck, lung, breast, cervix, colon carcinoma cells (Gires et al； 2005) and 
circulating CK8 protein expression is significantly associated with tumor progression 
and decreased survival in patients with non-small-cell lung cancer (Fukunaga et al., 
2002). 
4.4.1.1.4 RAN 
The RAN protein is the most abundant small GTPase in cells and is best 
known for its function in nucleocytoplasmic transport of both RNA and proteins 
(Wemierberg et al” 2005). Although overexpression of RAN may greatly alter cell 
cycle kinetics and cell viability, its involvement in cancer is still exploring. Recent 
report has indicated that RAN is upregulated in over 80% of nasopharyngeal 
carcinoma tissues (Li et al” 2006). Moreover, it is suggested that RAN may involve 
in prostate cancer formation (Pemberton et al., 2005). 
4.4.1.1.5 Heat shock protein 27 
Hsp27 is expressed in response to a wide variety of physiological and 
environmental stress conditions including anticancer therapy (Garrido et al” 2006). It 
is a molecular chaperone that can prevent cell death caused by toxic agents to 
promote apoptosis. Another cytoprotective effect of hsp27 is to increase the 
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tumorigenic potential of cancer cells (Ferns et al., 2006). Previous reports have 
shown that hsp27 would increase the risk of malignant progression in benign 
proliferative breast lesions (O'Neill et al” 2004) and it is a prognostic marker in 
breast cancer (Morino et al,, 1997), prostate cancer (Morino et al, 1997), and liver 
cancer (Luk et al, 2006). Our result indicates that hsp27 is a potential 5-FU 
response protein and further investigation of hsp27 expression in CRC specimens 
before and after 5-FU treatment would be carried out. In fact, hsp27 is a good 
predictor of response for esophageal squamous cell carcinoma (ESCC) using 5-FU in 
chemo-radiotherapy (Nakajima et al.’ 2002). 
4.4.1.1.6 Peroxiredoxin 6 
Prxs are a recently characterized group of stress inducible, thiol-containing 
proteins with efficient antioxidant capacity by reducing hydrogen peroxide to water 
(Miyazaki et al., 2005). The mammalian Prx family is divided into 6 groups (Prx 
I-IV) that located in the cytoplasm and involves in the cell signaling system 
(Karihtala et al, 2003). Prx 6 is overexpressed in mesothelioma and correlates with 
the development, recurrence and progression of bladder cancer (Quan et al., 2006). In 
fact, using the same proteoniics-based approach, Prx 6 is identified as a novel serum 
marker in ESCC (Fujita et al., 2006). To our knowledge, this is the first report of an 
upregulation of Prx 6 after 5-FU treatment in SW480 cells and this study confirms 
that Prx 6 is a potential 5-FU response proteins. Further evaluation of Prx 6 in 
chemotherapeutic applications is highly recommended in order to explore its 
potential in chemotherapeutic applications. 
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4.4.1.2 Identified downregulated proteins after 5-fluorouracil treatment in 
SW480 cells 
4.4.1.2.1 Heat shock protein 60 
Hsp60 is a mitochondrial protein involved in protein folding, transport, 
secretion and can activate apoptosis. Its overexpression has been reported in 
exo-cervix, prostate and colorectal carcinogenesis (Faried at al, 2004). Besides, 
hsp60 call be induced by photofrin-mediated photodynaniic therapy (PDT) in a 
PDT-induced resistant CRC cell line (Hanlon et al., 2001) and is a good prognostic 
marker to ESCC (Faried at al., 2004) and neoadjuvant chemoradiation in bladder 
cancer (Urushibara et al, 2007). 
4.4.1.2.2 Cytokeratin 18 
CKI 8 is the cytokeratin to be expressed in embryogenesis and it is expressed 
in gall bladder epithelium, mucosa of the small intestine and colon, hepatocytes, 
eccrine sweat glands, fallopian tube, cervix uteri and endometrium in adults (Moll et 
al., 1982). In addition, CKI 8 is overexpressed in proliferating tissues such as liver 
cirrhosis (Blaheta et al” 1998)，malignant tumors in colon (Prochasson et al； 1999)， 
breast (Schaller et al., 1996), ovarian, endometrium and cervix (Moll et al, 1983). 
4.4.1.2.3 Cytokeratin 9 
CK9 is expressed in most epidermal keratinocytes of soles and palms but 
only scanty keratinocytes in other body sites (Kiiapp et al,, 1986). Report on CK9 is 
very rare and previous work indicates that function of CK9 is to provide additional 
reinforcement in the stress-bearing palmoplantar epidermis (Swensson et al” 1998). 
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4.4.1.2.4 Carbamoylphosphate synthetase I 
CPSl is the first mitochondrial enzyme in urea cycle and it functions to 
convert toxic ammonia into urea in liver. A genetic mutation of CPSl has been 
identified as the cause of neonatal hyperammonemia. Apart from liver, CPSl is only 
expressed in the enterocytes of small intestine where it plays a key role in the 
synthesis of citmlline (Ryall et al, 1985). Previous studies indicate that CPSl is 
overexpressed in gastric cancer patients (Liu et al., 1989), whereas it is 
underexpressed in hepatocellular carcinoma patients (Kinoshita et al, 2002). 
4.4.1.2.5 a-Enolase 
ENOl is one of the three isoforms in the enolase enzyme family that involved 
in glycolytic metabolism. Besides, ENOl is the major form of enolase present in 
early stages of embryonic development and is expressed ubiquitously in different 
types of tissue (Chang et al,, 2006). Recent evidence has showed that ENOl is 
important in tuniorigenesis because ENOl overexpression is associated with poor 
prognosis in patients with non-small cell lung cancer (Chang et al., 2006) and may be 
involved in cancer invasion and metastasis (Chang et al., 2003). In contrast, ENOl 
also found to possess tumor suppressor activity by inducing apoptosis after 
transfection of ENOl mRNA into neuroblastoma cells (Ejeskar et al,, 2005). 
4.4.1.2.6 Heat shock protein 70 
Hsp70 is the major stress inducible, cancer-associated, anti-apoptotic protein 
(Jaattela et al., 1999). Increased expression of hsp70 has been reported in renal cell 
cancer (Atkins et al., 2005), gastric cancer (Isomoto et al., 2003), hepatocellular 
cancer (Chuma et al, 2003)，and CRC (Kanazawa et al.’ 2003). Besides, hsp70 
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expression is associated to imatinib resistance in chronic myeloid leukemia (Pocaly 
et al., 2007) and to curcumin resistance in colon SW480 cells (Rashmi et al, 2004). 
Similar to hsp27, hsp70 is a good response predictor for ESCC using 5-FU as a 
chemotherapeutic drug in chemo-radiotherapy and hsp70 is also a biomarker of 
cellular resistance in multimodal approaches which combine 5-FU and hyperthermia 
in the treatment of locally advanced prostate carcinoma (Roigas et al” 1998). The 
present data in this study shows that hsp70 is a potential 5-FU response protein and 
the expression of hsp70 in CRC specimens before and after 5-FU treatment would be 
examined. 
4.4.1.2.7 nm23 
Nm23 tumor metastasis suppressor gene is found to encode a protein identical 
to nucleoside diphosphate kinase (NDP kinase) with 8 different genes (nm23-Hl to 
nm23-H8) identified in humans. NDP kinases are responsible to transfer the 
gamma-phosphates between di- and tri-phosphonucleosides in order to provide cells 
with high-energy nucleosides other than ATP, and are also involved in a variety of 
different cellular processes (Foumier et al,, 2003). The role of nm23 in cancer is still 
poorly understood. Nm23-Hl is overexpressed in early stage CRC but not in 
advanced tumor stages (Martinez et al., 1995). Nni23-H4, mTi23-H6 and mii23-H7 
are involved in tumor development as they are overexpressed in colon and gastric 
cancer when compared to the adjacent normal tissues (Seifert et al., 2005). 
4.4.1.2.8 p-actin 
p-actin is the isofomi of actin that expresses in non-muscle cells (Popow et 
al,, 2006). There are scanty literatures reporting P-actin's expression in cancer 
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because it is usually used as a housekeeping genes or proteins (Azuma et al., 2006). 
However, recent studies have indicated that p-actin is overexpressed in many tumor 
cells especially in actively moving, highly invasive cells and therefore P-actin 
expression may be related to the metastatic potential of the cancer cell (Nowak et al., 
2005). 
4.4.2 Limitations of proteomics profiling 
Two-DE is not a very sensitive method to detect the differential expressed 
proteins. The abundances of proteins may exist in a dynamic range, in which the 
staining pattern of high abundance proteins (i.e. more than 100 ng) can be visualized 
with Coomassie brilliant blue staining. For the detection of low abundance proteins 
(i.e. between 1-10 ng), a more sensitive silver staining method should be used (Klose 
et al, 1995, Wetzel et al, 2006). Optimum conditions are essential for 2-DE because 
slight variation in the concentrations of chaotropic agents, detergents, ampholytes 
and reducing agents can dramatically affect the 2-DE pattern. Besides, the reagents 
used should be compatible with the techniques of lEF and IPG strips, for example the 
use of ionic agent SDS should be avoided as it is not compatible with lEF (A 
Methods and Product Manual of 2-D Electrophoresis for Proteomics, Biorad). On the 
other hand，the choice of protein samples should also be monitored as only a sample 
with low ionic strength in denaturing buffer can maintain the native charge and 
solubility during the separation process (A Methods and Product Manual of 2-D 
Electrophoresis for Proteomics, Biorad). As only proteins which showed a more than 
two-fold differential expression were subjected to identification by MALDI-TOF in 
this study, it is possible that some significant differential expressed genes encode for 
proteins with less than two-fold differential expression after series of 
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post-translational modification. This drawback can explain the discrepancies of 
mRNA and proteins identified by Q-RT-PCR and MS, respectively. 
Despite the above limitations, 2-DE was used in this study as it is a 
well-established method with high sample throughput. The main advantage of 2-DE 
is that it can resolve different expression forms of the same protein, and therefore it is 
ideal as a preliminary method to obtain an overview of the proteins expression 
pattern (Aebersold et al, 2003). In this study, ICC staining was used to verify the 
proteins' identities. Apart from ICC staining, western blotting is an alternative choice 
for confirmation of proteins' identities. 
4.4.3 Summary 
In summary, we have detected 14 differential expressed proteins using 
proteomics technology and would proceed with their validations using ICC staining. 
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Chapter 5 
Verification of proteins' identities by 
immunocytochemical staining 
5.1 Materials and Methods 
5.1.1 Antibodies 
Rabbit polyclonal anti-cyclophilin A antibody (PC270, Calbiochem, San 
Diego, CA92121, USA); mouse monoclonal aiiti-CK8 antibody (M0631, Clone 
35pHll , DakoCytomation, Glostrup, Denmark); mouse monoclonal anti-hsp27 
antibody (SPA-800, Clone G3.1，Stressgen Bioreagents Corporation, Victoria, BC， 
Canada); mouse anti-Prx 6 antibody (MAB3478, Clone 8H11, Chemicon 
International Inc, Temecula, CA, USA); mouse monoclonal anti-CK18 antibody 
(M7010, Clone DC 10, DakoCytomation, Glostrup, Denmark); mouse monoclonal 
anti-ENOl antibody (H00002023-M01, Clone 8G8, Abnova Corporation, Taipei, 
Taiwan); mouse monoclonal anti-hsp70 antibody (SPA-810, Clone C92F3A-5, 
Stressgen Bioreagents Corporation, Victoria, BC, Canada) were used. 
5.1.2 Treatment of cells 
SW480 cells were seeded in a 100 mm flat-bottom tissue culture plates (BD, 
Franklin Lakes, NJ, USA) and allowed to attach for 24 hours. After attachment, 5-FU 
was dissolved in double distilled water and added to fresh culture medium at a final 
concentration of 16.3 [iM whereas the same volume of autoclaved double distilled 
water was added in controls. The cells were then incubated for a further 72 hours at 
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37°C in a humidified incubator. 
5.1.3 Agar block preparation of SW480 cells 
The cells harvested after trypsinization were fixed in 10% buffered formalin 
for 18 hours followed by centrifuging at 1560 g for 10 minutes. The supernatant was 
discarded and 500 |iL of 2% agar was added to the cell pellet. The mixture was then 
placed on ice to solidify the agar with the cells followed by routine tissue processing 
to become paraffin embedded blocks for immunocytochemical (ICC) staining. 
5.1.4 Immunocytochemical staining and evaluation 
Serial tissue sections (4 jim thick) were cut and antigen retrieval was 
performed using Bond Epitope Retrieval Solution 2 on the Bond-max automated 
immuiiostainer (Vision BioSystems, Mount Waverley, Australia) at 100°C for 25 
minutes. Primary antibodies dilutions were prepared as follows: cyclophilin A, 1:150; 
CK8，1:100; hsp27, 1:400; Prx 6, 1:250; CK18, 1:100; ENOl, 1:15000; hsp70, 1:300. 
Staining was performed according to a standard protocol in the immuiiostainer. 
Polymer detection system was selected to avoid the problem of nonspecific 
endogenous biotin staining. Appropriate positive controls were used and they were as 
follows: non-small cell lung cancer cells for cyclophilin A; benign colon epithelial 
cells for CK8 and CK18; breast cancer cells for hsp27, ENOl and hsp70; benign 
prostate glandular epithelial cells for Prx 6. A positive control tissue was mounted on 
every test slide and negative controls were performed by replacing the antibody with 
Tris buffered saline. The stained slides were evaluated in 5 fields under light 
microscope at X400 magnification by 2 independent observers. All slides were scored 
semi-quantitatively and expressed as an ICC score by multiplying the "percentage of 
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positive cells" and the "staining intensity". Staining intensity was scored as follows: 
0，negative; 1, weak; 2，moderate; 3，strong; and 4, very strong. The ICC score 
ranged from 0 to 400. 
5.1.5 Polymer-based immunohistochemical detection system 
Polymer detection system was used in this study instead of avidin-biotin 
system. The non-avidin-biotin polymer-based methods have many secondary 
immunoglobulins and reporter molecules attached to an inert polymer backbone 
(Ramos-Vara 2005). The application of polymer detection system in 
immimohistochemistry has improved the quality of staining by eliminating the 
background produced by endogenous avidin-biotin activity with higher sensitivity 
and simplicity (Ramos-Vara 2005). 
5.1.6 Statistical analyses 
The differences in ICC scores of anti-cyclophilin A, anti-CK8, anti-hsp27, 
aiiti-Prx 6，anti-CK18, anti-ENOl and anti-hsp70 stainings between 5-FU treated and 
untreated SW480 cells were studied using Wilcoxon matched pairs test which is a 
nonparametric test that compares 2 paired groups. GraphPad Prism software version 
5.0 (GraphPad, Software Inc，San Diego, California, USA) was used for all statistical 
analyses and P<0.05 was considered significant. 
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5.2 Results 
5.2.1 Confirmation of proteomic Endings using immunocytochemical stainings 
in paraffin-embedded sections of 5-fluorouracil treated and untreated 
SW480 cells 
Seven antibodies that include anti-cyclopliilin A, anti-CK8, anti-hsp27, 
anti-Prx 6，anti-CK18, anti-ENOl and anti-hsp70 were successfully optimized with 
strong signals and a clean background. Cellular localization of the 7 proteins was as 
follows (Table 5.1): nucleus and cytoplasmic expression for cyclophilin A, ENOl 
and hsp70; cytoplasmic expression for lisp27, Prx 6; and cytoskeletal network for 
CK8 and CK18. In general, the percentage of positive cells and staining intensity of 
anti-hsp27 and anti-Prx 6 were higher in 5-FU treated than control SW480 cells 
(Figure 5.1A-D). On the other hand, the percentage of positive cells and staining 
intensity of anti-hsp70 was lower in 5-FU treated than control SW480 cells (Figure 
5.1E-F). For anti-cyclophilin A, aiiti-CK8, anti-CK18 and anti-ENOl staining, 
similar staining pattern was observed (Figures 5.1G-N). The ICC scores for those 7 
antibodies staining in 5-FU treated and control SW480 cells were shown in Figure 
5.2. The differences in ICC scores between 5-FU treated and control SW480 cells for 
hsp27, Prx 6 and hsp70 stainings were significant (P<0.05, Wilcoxon matched pairs 
test). For CK19，RAN, hsp60, CK9, CPSl, mn23 and P-actin proteins, stainings had 
not been performed due to either antibodies were not available or the antibodies 
could not be optimized well in the immunostainers. 
Cellular localization Protein Ratio 
Nucleus and Cytoplasm cyclophilin A ~ 
a-enolase -4.2 
heat shock protein 70 -8.9 
Cytoplasm heat shock protein 27 +8.6 
peroxiredoxi门 6 +10.9 
Cytoskeletal network cytokeratin 8 +4.5 
cytokeratin 18 -3.6 
Table 5.1 Cellular localization of cyclophilin A,cytokeratin 8, heat shock protein 27, 
peroxiredoxin 6, cytokeratin 18, a-enolase and heat shock protein 70 in SW480 cells. 
A positve value for ratio inducates an increased expression after 5-FU treatment, 
whereas a negative value for ratio indicates a decreased expression after 5-FU treatment. 
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Figure 5.1 Immunostaining in paraffin embedded sections of 5-FU treated 
and control SW480 cells. A. Hsp27 in 5-FU treated cells, B.Hsp27 in control 
cells, C. Prx 6 in 5-FU treated cells, D. Prx 6 in control cells, E. Hsp70 in 5-
FU treated cells, F. Hsp70 in control cells, G. Cyclophilin A in 5-FU treated 
cells, H. Cyclophilin A in control cells, 1. CK8 in 5-FU treated cells, J. CK8 
in control cells，K. CK18 in 5-FU treated cells, L. CK18 in control cells，M. 
ENOl in 5-FU treated cells, and N. ENOl in control cells (original 
magnifications X 400). 
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Figure 5.2 ICC scores of lisp27, Prx 6，hsp70, Cyclophilin A, CK8, CKl 8 and ENOl in 
5-FU treated and control SW480 cells. ICC scores were obtained by multiplying the 
"percentage of positive cells" and the "staining intensity". Staining intensity was scored 
as follows: 0, negative; 1，weak; 2，moderate; 3, strong; and 4, very strong. The ICC 
score ranged from 0 to 400. Differences in ICC scores for hsp27, Prx 6 and hsp70 
stainings were significant (P<0.05, Wilcoxon matched pairs test). 
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5.3 Discussion 
5.3.1 Immunocytochemical staining to verify proteomics findings of 
5-fluorouracil treated and untreated SW480 cells 
It is always important to validate the 2-DE results using alternative 
approaches. ICC staining is one of the choices since it is crucial to validate the 
results of the protein expression at the cellular level. One of the major drawbacks 
was the unavailability of antibodies for some identified proteins. 
Using ICC staining, 3 (hsp27, Prx 6 and hsp70) of the 7 proteins were found 
to have the same expression pattern as those from 2-DE whereas the remaining 4 
proteins (cyclophilin A, CK8, CK18 and ENOl) did not have any significant 
difference after 5-FU treatment. Based on the fact that the fold changes, as indicated 
by 2-DE, of the 3 proteins with significant differences in percentage of positive cells 
and staining intensity ranged from 8.6 to 10.9 (hsp27, Prx 6 and hsp70) whereas the 
fold changes from the other 4 proteins without any significant difference in ICC 
staining ranged from 2.8 to 4.5 (cyclophilin A, CK8, CK18 and ENOl). Therefore 
we speculate that ICC staining may not be sensitive enough to detect a smaller fold 
change indicated by 2-DE and a more sensitive ICC detection system should be 
developed in the future so that proteins with smaller fold change can be confirmed. 
Nevertheless, ICC detection is still very important for confirmation of differential 
expressed proteins detected from proteomics not only because the percentage of 
positive cells and the staining intensity can be assessed, but also the cellular origin 
with the localization of the differential expressed protein can be examined under 
microscope. 
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5.3.2 Limitations of ICC staining 
The identities of 4 proteins, including cyclophilin A, CK8, CKI8 and ENOl, 
cannot be verified by ICC staining even though their antibodies can be optimized 
with a strong signal and clean background. These discrepancies may be explained by 
the fact that ICC staining detects the expression from all forms of the same proteins 
in total, whereas 2-DE can resolve different expression forms of the same protein. 
Therefore, the differential expression of a particular form of a protein may not 
necessarily leads to an overall differential expression. Hence the differential 
expressed proteins identified by proteomics profiling and confirmation of a particular 
protein using ICC staining may be varied. 
5.3.3 Summary 
111 summary, ICC staining confirms hsp27, Prx 6 were upregulated and hsp70 
was downregulated in SW480 cells after treating with 5-FU for 72 hours. 
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Chapter 6 
Conclusions and Future Perspectives 
6.1 Significance of study 
In summary, this study is the first to show the effect of 5-FU in CRC SW480 
cells which was verified as a nuclear p-catenin positive cell line by ICC staining. IC50 
value of 5-FU treatment at 72 hours was determined to be 16.33±2.11 |iM by MTT 
assay. 
In order to study the effect of 5-FU on mRNA expression in SW480 cells, 
Q-RT-PCR arrays were used to measure the expression of 84 genes that belong to 
several families related to Wnt-mediated signal transduction. These include 
extracellular signaling molecules, members of canonical Wnt signaling pathway, 
regulators of cell cycle, regulators of growth and proliferation, regulators of 
transcription, regulators of Wnt receptor signaling pathway and other genes involved 
in Wnt signaling. Results indicated that after treating SW480 cells with 5-FU for 72 
hours, FRZB, DKKl, Wnt-9A, FOSLl, PORCN homolog, Myc, DVLl, FRAT, Jim 
oncogene, APC, PITX2, cyclin D3 and Bcl-9 were upregulated whereas S0X17, 
Wnt-11 and Wnt-2 were downregulated with at least 2-fold differential expression 
when compare to that without 5-FU treatment. 
In order to have a global understanding of proteins expression on 5-FU 
treatment in SW480 cells, 2-DE and MALDI-TOF MS were used and revealed that a 
total of 204 proteins were modulated by 5-FU with at least 2-fold differential 
expression. Among them, 114 proteins were upregulated and 90 proteins were 
downregulated. In addition, 14 spots with the highest fold change were excised for 
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proteins identification. Upregulated proteins were identified as cyclophilin A, CK8, 
CKl9, RAN, hsp27, Prx 6 whereas downregulated proteins were identified as nm23, 
ENOl, CPSl, CK9, CKl8, P-actin, hsp70 and hsp60. Those proteins belong to 
several families which involve in cell signaling, epithelial cells development, 
enzymatic reactions, proteins folding and transport. Verification of the proteomic 
findings by anti-cyclophilin A, anti-CK8, anti-hsp27, anti-Prx 6, anti-CK18, 
anti-ENOl and anti-hsp70 antibodies stainings were performed on 5-FU treated and 
untreated SW480 cells. Results showed that hsp27, Prx 6 and hsp70 had the same 
expression pattern as those from proteomics. The findings are important because it 
demonstrates the application of a powerful global proteomic and ICC approach 
which successfully discovered the upregulation of hsp27, Prx 6 and downregulation 
of hsp70 as 5-FU response proteins. 
6.2 Future perspectives 
In the past decade, the median survival for patients with metastatic CRC has 
nearly doubled from 12 months to 22 months (Coyle et al, 2006). Despite this 
improvement, there are still a significant number of patients who do not benefit from 
treatment. Hence there is a need to identify novel panels of biomarkers that can be 
used to predict which patients will respond to chemotherapeutics treatment (Coyle et 
al, 2006). So that patients with no response can change to another treatment strategy 
promptly. Biomarkers are important as molecular signals of the physiological state of 
a cell. The importance of biomarker lies in its ability to provide an early indication of 
the disease, to monitor disease progression, to provide ease of detection, and to 
provide a factor measurable across populations (Lander et al, 2001). 
There are different types of molecular biomarkers including DNA, mRNA, 
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proteins, antigens or hormones measured quantitatively and/or qualitatively by 
appropriate assays. Biomarker assays comprise imiiiuiiohistocytochemical (IHC) test, 
quantitative immunoassays, PCR, western or northern blot and more recently 
microarrays (genomic and proteomic) and mass spectrometry. Currently, there are 
limitations in the existing biomarkers such as low specificity and excess sensitivity 
that prevent their widespread clinical applications. 
Genomics offers the opportunity to examine gene expression or the variation in 
gene sequence, whereas proteomics encompasses evaluation of protein expression, 
activation, modification, degradation, and protein functions. The human proteome, 
due to the enormity of post-translational permutations that result in large number of 
isoforms, is much more complex than the genome and therefore it is essential to 
study both genomics and proteomics expression as shown in this study. 
Our work，using Q-RT-PCR and proteomics profiling to identify some 
differentially expressed genes and proteins after 5-FU treatment in SW480 cells is 
preliminary, but novel. These identified genes and proteins may act as biomarkers to 
predict response of SW480 cells to 5-FU. Further work to detect the identified 
mRNA and proteins' expressions in other 5-FU sensitive CRC cell lines such as 
SNU-C4, LoVo and in 5-FU resistant cell lines such as HT-29, ContinB would enable 
us to study the potential of them in predicting 5-FU treatment response. Moreover, 
detailed investigation of the functional role of those molecular targets identified in 
this study would improve our understanding in the chemotherapeutic effects of 5-FU. 
The goals in cancer research include finding biomarkers that can be used for the 
early detection of cancers, design individual therapies, and to identify underlying 
processes involved in the disease. The aim is similar to "finding a needle in a 
haystack". However, the rapid development of advanced technologies has allowed us 
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to detect useful biomarkers in a more efficient and accurate platforms. Although 
there are still many challenges ahead in translating the biomarker discoveries into 
clinical applications, we are confident that our study has laid down a solid foundation 
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